In total 341 out of top-10 predicted DTIs per drug were validated.
In total, 618 validated new DTIs are known for gpcr dataset, however please note that at most 465 DTIs could be predicted (i.e., some drugs have more than 10 validated DTIs).
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.907703 | 1 | 0 | 1 | 0 |
2 | hsa185 ( angiotensin II receptor type 1 ) | 0.727639 | 0 | 0 | 0 | 0 |
3 | hsa154 ( adrenoceptor beta 2 ) | 0.712188 | 0 | 0 | 0 | 0 |
4 | hsa153 ( adrenoceptor beta 1 ) | 0.689806 | 0 | 0 | 0 | 0 |
5 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.66573 | 0 | 0 | 0 | 0 |
6 | hsa222545 ( G protein-coupled receptor class C group 6 member A ) | 0.624499 | 0 | 0 | 0 | 0 |
7 | hsa1813 ( dopamine receptor D2 ) | 0.613097 | 0 | 0 | 0 | 0 |
8 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.605993 | 0 | 0 | 0 | 0 |
9 | hsa4988 ( opioid receptor mu 1 ) | 0.603404 | 0 | 0 | 0 | 0 |
10 | hsa6010 ( rhodopsin ) | 0.597581 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1814 ( dopamine receptor D3 ) | 0.931127 | 1 | 1 | 1 | 0 |
2 | hsa1816 ( dopamine receptor D5 ) | 0.881399 | 1 | 1 | 1 | 0 |
3 | hsa154 ( adrenoceptor beta 2 ) | 0.804541 | 0 | 0 | 0 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.795459 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.775413 | 0 | 0 | 0 | 0 |
6 | hsa153 ( adrenoceptor beta 1 ) | 0.770575 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.76211 | 0 | 0 | 0 | 0 |
8 | hsa151 ( adrenoceptor alpha 2B ) | 0.751384 | 0 | 0 | 0 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.74428 | 0 | 0 | 0 | 0 |
10 | hsa4985 ( opioid receptor delta 1 ) | 0.651287 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5731 ( prostaglandin E receptor 1 ) | 0.941942 | 1 | 0 | 1 | 0 |
2 | hsa5737 ( prostaglandin F receptor ) | 0.906 | 0 | 0 | 0 | 0 |
3 | hsa5732 ( prostaglandin E receptor 2 ) | 0.870486 | 1 | 1 | 1 | 0 |
4 | hsa5733 ( prostaglandin E receptor 3 ) | 0.791449 | 1 | 0 | 1 | 0 |
5 | hsa64805 ( purinergic receptor P2Y12 ) | 0.723763 | 0 | 0 | 0 | 0 |
6 | hsa6915 ( thromboxane A2 receptor ) | 0.714098 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.711709 | 0 | 0 | 0 | 0 |
8 | hsa153 ( adrenoceptor beta 1 ) | 0.701301 | 0 | 0 | 0 | 0 |
9 | hsa3269 ( histamine receptor H1 ) | 0.650125 | 0 | 0 | 0 | 0 |
10 | hsa4988 ( opioid receptor mu 1 ) | 0.631017 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa185 ( angiotensin II receptor type 1 ) | 0.773193 | 0 | 0 | 0 | 0 |
2 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.720709 | 0 | 0 | 0 | 0 |
3 | hsa150 ( adrenoceptor alpha 2A ) | 0.683609 | 0 | 0 | 0 | 0 |
4 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.675475 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.662581 | 0 | 0 | 0 | 0 |
6 | hsa152 ( adrenoceptor alpha 2C ) | 0.631487 | 0 | 0 | 0 | 0 |
7 | hsa151 ( adrenoceptor alpha 2B ) | 0.629329 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.617708 | 0 | 0 | 0 | 0 |
9 | hsa4988 ( opioid receptor mu 1 ) | 0.601763 | 0 | 0 | 0 | 0 |
10 | hsa23620 ( neurotensin receptor 2 ) | 0.578044 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa155 ( adrenoceptor beta 3 ) | 0.940071 | 1 | 1 | 1 | 0 |
2 | hsa146 ( adrenoceptor alpha 1D ) | 0.842186 | 1 | 1 | 1 | 0 |
3 | hsa147 ( adrenoceptor alpha 1B ) | 0.831339 | 1 | 1 | 1 | 0 |
4 | hsa3274 ( histamine receptor H2 ) | 0.762238 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.676406 | 1 | 1 | 1 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.671383 | 1 | 1 | 1 | 0 |
7 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.555688 | 0 | 0 | 0 | 0 |
8 | hsa1812 ( dopamine receptor D1 ) | 0.537359 | 0 | 0 | 0 | 0 |
9 | hsa152 ( adrenoceptor alpha 2C ) | 0.537266 | 1 | 1 | 1 | 0 |
10 | hsa3269 ( histamine receptor H1 ) | 0.531445 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5739 ( prostaglandin I2 (prostacyclin) receptor (IP) ) | 0.805892 | 1 | 1 | 1 | 0 |
2 | hsa5731 ( prostaglandin E receptor 1 ) | 0.738412 | 0 | 0 | 0 | 0 |
3 | hsa5737 ( prostaglandin F receptor ) | 0.723369 | 0 | 0 | 0 | 0 |
4 | hsa4988 ( opioid receptor mu 1 ) | 0.708229 | 0 | 0 | 0 | 0 |
5 | hsa185 ( angiotensin II receptor type 1 ) | 0.707933 | 0 | 0 | 0 | 0 |
6 | hsa134 ( adenosine A1 receptor ) | 0.679691 | 0 | 0 | 0 | 0 |
7 | hsa136 ( adenosine A2b receptor ) | 0.667929 | 0 | 0 | 0 | 0 |
8 | hsa135 ( adenosine A2a receptor ) | 0.652286 | 0 | 0 | 0 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.64307 | 0 | 0 | 0 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.635878 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4988 ( opioid receptor mu 1 ) | 0.931873 | 0 | 0 | 0 | 0 |
2 | hsa1813 ( dopamine receptor D2 ) | 0.928317 | 0 | 0 | 0 | 0 |
3 | hsa4985 ( opioid receptor delta 1 ) | 0.895145 | 0 | 0 | 0 | 0 |
4 | hsa1816 ( dopamine receptor D5 ) | 0.862505 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.766664 | 0 | 0 | 0 | 0 |
6 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.697207 | 0 | 0 | 0 | 0 |
7 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.687305 | 1 | 0 | 1 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.67916 | 0 | 0 | 0 | 0 |
9 | hsa185 ( angiotensin II receptor type 1 ) | 0.673399 | 0 | 0 | 0 | 0 |
10 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.66728 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3269 ( histamine receptor H1 ) | 0.936278 | 0 | 0 | 0 | 0 |
2 | hsa1813 ( dopamine receptor D2 ) | 0.648265 | 0 | 0 | 0 | 0 |
3 | hsa4988 ( opioid receptor mu 1 ) | 0.629282 | 0 | 0 | 0 | 0 |
4 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.570224 | 0 | 0 | 0 | 0 |
5 | hsa154 ( adrenoceptor beta 2 ) | 0.567054 | 0 | 0 | 0 | 0 |
6 | hsa1815 ( dopamine receptor D4 ) | 0.562958 | 0 | 0 | 0 | 0 |
7 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.560831 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.549081 | 0 | 0 | 0 | 0 |
9 | hsa11255 ( histamine receptor H3 ) | 0.541475 | 0 | 0 | 0 | 0 |
10 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.51099 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa152 ( adrenoceptor alpha 2C ) | 0.919899 | 0 | 0 | 0 | 0 |
2 | hsa1812 ( dopamine receptor D1 ) | 0.904972 | 1 | 0 | 1 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.901064 | 1 | 0 | 0 | 1 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.885969 | 1 | 0 | 1 | 0 |
5 | hsa146 ( adrenoceptor alpha 1D ) | 0.870714 | 1 | 0 | 0 | 1 |
6 | hsa147 ( adrenoceptor alpha 1B ) | 0.856573 | 1 | 0 | 0 | 1 |
7 | hsa1816 ( dopamine receptor D5 ) | 0.799201 | 0 | 0 | 0 | 0 |
8 | hsa3269 ( histamine receptor H1 ) | 0.725857 | 0 | 0 | 0 | 0 |
9 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.697801 | 1 | 0 | 0 | 1 |
10 | hsa1815 ( dopamine receptor D4 ) | 0.622077 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa185 ( angiotensin II receptor type 1 ) | 0.793167 | 0 | 0 | 0 | 0 |
2 | hsa154 ( adrenoceptor beta 2 ) | 0.667299 | 0 | 0 | 0 | 0 |
3 | hsa150 ( adrenoceptor alpha 2A ) | 0.663563 | 0 | 0 | 0 | 0 |
4 | hsa153 ( adrenoceptor beta 1 ) | 0.652562 | 0 | 0 | 0 | 0 |
5 | hsa4988 ( opioid receptor mu 1 ) | 0.620268 | 0 | 0 | 0 | 0 |
6 | hsa136 ( adenosine A2b receptor ) | 0.618639 | 0 | 0 | 0 | 0 |
7 | hsa134 ( adenosine A1 receptor ) | 0.596724 | 0 | 0 | 0 | 0 |
8 | hsa1813 ( dopamine receptor D2 ) | 0.595125 | 0 | 0 | 0 | 0 |
9 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.582632 | 0 | 0 | 0 | 0 |
10 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.582523 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5733 ( prostaglandin E receptor 3 ) | 0.942957 | 0 | 0 | 0 | 0 |
2 | hsa5737 ( prostaglandin F receptor ) | 0.939642 | 0 | 0 | 0 | 0 |
3 | hsa6915 ( thromboxane A2 receptor ) | 0.820854 | 0 | 0 | 0 | 0 |
4 | hsa4988 ( opioid receptor mu 1 ) | 0.680603 | 0 | 0 | 0 | 0 |
5 | hsa5729 ( prostaglandin D2 receptor ) | 0.677384 | 0 | 0 | 0 | 0 |
6 | hsa64805 ( purinergic receptor P2Y12 ) | 0.654855 | 0 | 0 | 0 | 0 |
7 | hsa153 ( adrenoceptor beta 1 ) | 0.638273 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.637655 | 0 | 0 | 0 | 0 |
9 | hsa3274 ( histamine receptor H2 ) | 0.615052 | 0 | 0 | 0 | 0 |
10 | hsa10800 ( cysteinyl leukotriene receptor 1 ) | 0.594109 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa185 ( angiotensin II receptor type 1 ) | 0.797381 | 0 | 0 | 0 | 0 |
2 | hsa150 ( adrenoceptor alpha 2A ) | 0.680489 | 0 | 0 | 0 | 0 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.663329 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.659882 | 0 | 0 | 0 | 0 |
5 | hsa154 ( adrenoceptor beta 2 ) | 0.603602 | 0 | 0 | 0 | 0 |
6 | hsa153 ( adrenoceptor beta 1 ) | 0.595537 | 0 | 0 | 0 | 0 |
7 | hsa4988 ( opioid receptor mu 1 ) | 0.592707 | 0 | 0 | 0 | 0 |
8 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.591479 | 0 | 0 | 0 | 0 |
9 | hsa151 ( adrenoceptor alpha 2B ) | 0.590233 | 0 | 0 | 0 | 0 |
10 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.58915 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa136 ( adenosine A2b receptor ) | 0.945137 | 0 | 0 | 0 | 0 |
2 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.854606 | 0 | 0 | 0 | 0 |
3 | hsa64805 ( purinergic receptor P2Y12 ) | 0.774109 | 0 | 0 | 0 | 0 |
4 | hsa185 ( angiotensin II receptor type 1 ) | 0.768488 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.672349 | 0 | 0 | 0 | 0 |
6 | hsa154 ( adrenoceptor beta 2 ) | 0.642423 | 0 | 0 | 0 | 0 |
7 | hsa5731 ( prostaglandin E receptor 1 ) | 0.615789 | 0 | 0 | 0 | 0 |
8 | hsa6915 ( thromboxane A2 receptor ) | 0.61186 | 0 | 0 | 0 | 0 |
9 | hsa153 ( adrenoceptor beta 1 ) | 0.609565 | 0 | 0 | 0 | 0 |
10 | hsa5029 ( purinergic receptor P2Y2 ) | 0.598478 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.914212 | 1 | 1 | 0 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.904487 | 0 | 0 | 0 | 0 |
3 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.87923 | 1 | 1 | 0 | 0 |
4 | hsa4988 ( opioid receptor mu 1 ) | 0.659388 | 0 | 0 | 0 | 0 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.627981 | 0 | 0 | 0 | 0 |
6 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.557906 | 0 | 0 | 0 | 0 |
7 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.550128 | 0 | 0 | 0 | 0 |
8 | hsa185 ( angiotensin II receptor type 1 ) | 0.548019 | 0 | 0 | 0 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.547162 | 0 | 0 | 0 | 0 |
10 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.542243 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.788897 | 0 | 0 | 0 | 0 |
2 | hsa1813 ( dopamine receptor D2 ) | 0.739942 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.691814 | 0 | 0 | 0 | 0 |
4 | hsa1812 ( dopamine receptor D1 ) | 0.67541 | 0 | 0 | 0 | 0 |
5 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.663024 | 0 | 0 | 0 | 0 |
6 | hsa3274 ( histamine receptor H2 ) | 0.657514 | 0 | 0 | 0 | 0 |
7 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.625764 | 0 | 0 | 0 | 0 |
8 | hsa4988 ( opioid receptor mu 1 ) | 0.624952 | 0 | 0 | 0 | 0 |
9 | hsa23620 ( neurotensin receptor 2 ) | 0.591225 | 0 | 0 | 0 | 0 |
10 | hsa154 ( adrenoceptor beta 2 ) | 0.574847 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa155 ( adrenoceptor beta 3 ) | 0.935568 | 1 | 0 | 0 | 1 |
2 | hsa3274 ( histamine receptor H2 ) | 0.689467 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.684525 | 0 | 0 | 0 | 0 |
4 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.613616 | 0 | 0 | 0 | 0 |
5 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.572341 | 0 | 0 | 0 | 0 |
6 | hsa146 ( adrenoceptor alpha 1D ) | 0.54959 | 0 | 0 | 0 | 0 |
7 | hsa1812 ( dopamine receptor D1 ) | 0.548066 | 0 | 0 | 0 | 0 |
8 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.532653 | 0 | 0 | 0 | 0 |
9 | hsa150 ( adrenoceptor alpha 2A ) | 0.532387 | 0 | 0 | 0 | 0 |
10 | hsa147 ( adrenoceptor alpha 1B ) | 0.516897 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1813 ( dopamine receptor D2 ) | 0.747099 | 0 | 0 | 0 | 0 |
2 | hsa222545 ( G protein-coupled receptor class C group 6 member A ) | 0.72349 | 0 | 0 | 0 | 0 |
3 | hsa6915 ( thromboxane A2 receptor ) | 0.703266 | 0 | 0 | 0 | 0 |
4 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.701355 | 0 | 0 | 0 | 0 |
5 | hsa185 ( angiotensin II receptor type 1 ) | 0.690968 | 0 | 0 | 0 | 0 |
6 | hsa1812 ( dopamine receptor D1 ) | 0.644934 | 0 | 0 | 0 | 0 |
7 | hsa64805 ( purinergic receptor P2Y12 ) | 0.641656 | 0 | 0 | 0 | 0 |
8 | hsa1814 ( dopamine receptor D3 ) | 0.632852 | 0 | 0 | 0 | 0 |
9 | hsa4988 ( opioid receptor mu 1 ) | 0.611777 | 0 | 0 | 0 | 0 |
10 | hsa154 ( adrenoceptor beta 2 ) | 0.6044 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa152 ( adrenoceptor alpha 2C ) | 0.867871 | 1 | 0 | 1 | 0 |
2 | hsa3274 ( histamine receptor H2 ) | 0.661977 | 0 | 0 | 0 | 0 |
3 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.617847 | 0 | 0 | 0 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.565293 | 0 | 0 | 0 | 0 |
5 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.560061 | 0 | 0 | 0 | 0 |
6 | hsa3269 ( histamine receptor H1 ) | 0.55541 | 0 | 0 | 0 | 0 |
7 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.547141 | 0 | 0 | 0 | 0 |
8 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.497421 | 0 | 0 | 0 | 0 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.492331 | 0 | 0 | 0 | 0 |
10 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.464554 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3269 ( histamine receptor H1 ) | 0.871011 | 1 | 1 | 1 | 0 |
2 | hsa152 ( adrenoceptor alpha 2C ) | 0.801394 | 1 | 1 | 1 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.77761 | 1 | 0 | 1 | 0 |
4 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.729134 | 1 | 1 | 1 | 0 |
5 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.706383 | 1 | 1 | 1 | 0 |
6 | hsa146 ( adrenoceptor alpha 1D ) | 0.68708 | 1 | 0 | 1 | 0 |
7 | hsa1815 ( dopamine receptor D4 ) | 0.672977 | 1 | 0 | 1 | 0 |
8 | hsa147 ( adrenoceptor alpha 1B ) | 0.65579 | 1 | 0 | 1 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.631687 | 0 | 0 | 0 | 0 |
10 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.591602 | 1 | 1 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3269 ( histamine receptor H1 ) | 0.862649 | 0 | 0 | 0 | 0 |
2 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.85199 | 0 | 0 | 0 | 0 |
3 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.739906 | 0 | 0 | 0 | 0 |
4 | hsa154 ( adrenoceptor beta 2 ) | 0.694484 | 0 | 0 | 0 | 0 |
5 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.676807 | 0 | 0 | 0 | 0 |
6 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.668101 | 1 | 0 | 1 | 0 |
7 | hsa1812 ( dopamine receptor D1 ) | 0.658224 | 0 | 0 | 0 | 0 |
8 | hsa3362 ( 5-hydroxytryptamine receptor 6 ) | 0.635281 | 0 | 0 | 0 | 0 |
9 | hsa1813 ( dopamine receptor D2 ) | 0.63423 | 0 | 0 | 0 | 0 |
10 | hsa148 ( adrenoceptor alpha 1A ) | 0.617243 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.659689 | 1 | 0 | 0 | 1 |
2 | hsa153 ( adrenoceptor beta 1 ) | 0.65347 | 0 | 0 | 0 | 0 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.638566 | 0 | 0 | 0 | 0 |
4 | hsa154 ( adrenoceptor beta 2 ) | 0.605509 | 0 | 0 | 0 | 0 |
5 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.586057 | 0 | 0 | 0 | 0 |
6 | hsa185 ( angiotensin II receptor type 1 ) | 0.581703 | 0 | 0 | 0 | 0 |
7 | hsa155 ( adrenoceptor beta 3 ) | 0.562777 | 0 | 0 | 0 | 0 |
8 | hsa3274 ( histamine receptor H2 ) | 0.538735 | 0 | 0 | 0 | 0 |
9 | hsa3269 ( histamine receptor H1 ) | 0.529668 | 0 | 0 | 0 | 0 |
10 | hsa3363 ( 5-hydroxytryptamine receptor 7 ) | 0.516905 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1814 ( dopamine receptor D3 ) | 0.932327 | 1 | 0 | 1 | 1 |
2 | hsa152 ( adrenoceptor alpha 2C ) | 0.751564 | 1 | 0 | 1 | 0 |
3 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.668531 | 1 | 0 | 1 | 0 |
4 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.590385 | 1 | 0 | 1 | 0 |
5 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.550672 | 1 | 0 | 1 | 0 |
6 | hsa3274 ( histamine receptor H2 ) | 0.493377 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.464469 | 0 | 0 | 0 | 0 |
8 | hsa11255 ( histamine receptor H3 ) | 0.459317 | 0 | 0 | 0 | 0 |
9 | hsa153 ( adrenoceptor beta 1 ) | 0.444063 | 0 | 0 | 0 | 0 |
10 | hsa155 ( adrenoceptor beta 3 ) | 0.352834 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.839386 | 0 | 0 | 0 | 0 |
2 | hsa153 ( adrenoceptor beta 1 ) | 0.813715 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.749967 | 0 | 0 | 0 | 0 |
4 | hsa3269 ( histamine receptor H1 ) | 0.727448 | 0 | 0 | 0 | 0 |
5 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.697506 | 0 | 0 | 0 | 0 |
6 | hsa59340 ( histamine receptor H4 ) | 0.688039 | 0 | 0 | 0 | 0 |
7 | hsa155 ( adrenoceptor beta 3 ) | 0.673099 | 0 | 0 | 0 | 0 |
8 | hsa136 ( adenosine A2b receptor ) | 0.628982 | 0 | 0 | 0 | 0 |
9 | hsa147 ( adrenoceptor alpha 1B ) | 0.626942 | 0 | 0 | 0 | 0 |
10 | hsa146 ( adrenoceptor alpha 1D ) | 0.615554 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.873525 | 0 | 0 | 0 | 0 |
2 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.78571 | 1 | 0 | 1 | 0 |
3 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.744745 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.676747 | 0 | 0 | 0 | 0 |
5 | hsa3274 ( histamine receptor H2 ) | 0.670961 | 0 | 0 | 0 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.645796 | 0 | 0 | 0 | 0 |
7 | hsa4988 ( opioid receptor mu 1 ) | 0.61454 | 0 | 0 | 0 | 0 |
8 | hsa23620 ( neurotensin receptor 2 ) | 0.611514 | 0 | 0 | 0 | 0 |
9 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.593655 | 0 | 0 | 0 | 0 |
10 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.572325 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4986 ( opioid receptor kappa 1 ) | 0.909566 | 0 | 0 | 0 | 0 |
2 | hsa4985 ( opioid receptor delta 1 ) | 0.814708 | 0 | 0 | 0 | 0 |
3 | hsa185 ( angiotensin II receptor type 1 ) | 0.796067 | 0 | 0 | 0 | 0 |
4 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.717855 | 0 | 0 | 0 | 0 |
5 | hsa6752 ( somatostatin receptor 2 ) | 0.715919 | 0 | 0 | 0 | 0 |
6 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.689469 | 0 | 0 | 0 | 0 |
7 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.669289 | 0 | 0 | 0 | 0 |
8 | hsa6755 ( somatostatin receptor 5 ) | 0.668708 | 0 | 0 | 0 | 0 |
9 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.65601 | 0 | 0 | 0 | 0 |
10 | hsa3269 ( histamine receptor H1 ) | 0.655621 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.735976 | 0 | 0 | 0 | 0 |
2 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.735566 | 0 | 0 | 0 | 0 |
3 | hsa136 ( adenosine A2b receptor ) | 0.732012 | 0 | 0 | 0 | 0 |
4 | hsa153 ( adrenoceptor beta 1 ) | 0.697511 | 0 | 0 | 0 | 0 |
5 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.660756 | 0 | 0 | 0 | 0 |
6 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.649275 | 0 | 0 | 0 | 0 |
7 | hsa3274 ( histamine receptor H2 ) | 0.640139 | 0 | 0 | 0 | 0 |
8 | hsa4988 ( opioid receptor mu 1 ) | 0.633888 | 0 | 0 | 0 | 0 |
9 | hsa150 ( adrenoceptor alpha 2A ) | 0.619597 | 0 | 0 | 0 | 0 |
10 | hsa222545 ( G protein-coupled receptor class C group 6 member A ) | 0.619527 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3269 ( histamine receptor H1 ) | 0.854999 | 0 | 0 | 0 | 0 |
2 | hsa154 ( adrenoceptor beta 2 ) | 0.769471 | 0 | 0 | 0 | 0 |
3 | hsa153 ( adrenoceptor beta 1 ) | 0.766538 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.737515 | 0 | 0 | 0 | 0 |
5 | hsa5731 ( prostaglandin E receptor 1 ) | 0.595654 | 0 | 0 | 0 | 0 |
6 | hsa5739 ( prostaglandin I2 (prostacyclin) receptor (IP) ) | 0.593899 | 0 | 0 | 0 | 0 |
7 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.592228 | 0 | 0 | 0 | 0 |
8 | hsa155 ( adrenoceptor beta 3 ) | 0.581665 | 0 | 0 | 0 | 0 |
9 | hsa5733 ( prostaglandin E receptor 3 ) | 0.565049 | 0 | 0 | 0 | 0 |
10 | hsa6915 ( thromboxane A2 receptor ) | 0.550227 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa152 ( adrenoceptor alpha 2C ) | 0.927724 | 0 | 0 | 0 | 0 |
2 | hsa151 ( adrenoceptor alpha 2B ) | 0.917592 | 0 | 0 | 0 | 0 |
3 | hsa135 ( adenosine A2a receptor ) | 0.902236 | 0 | 0 | 0 | 0 |
4 | hsa136 ( adenosine A2b receptor ) | 0.852107 | 0 | 0 | 0 | 0 |
5 | hsa140 ( adenosine A3 receptor ) | 0.81013 | 0 | 0 | 0 | 0 |
6 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.775608 | 0 | 0 | 0 | 0 |
7 | hsa146 ( adrenoceptor alpha 1D ) | 0.656732 | 0 | 0 | 0 | 0 |
8 | hsa185 ( angiotensin II receptor type 1 ) | 0.65096 | 0 | 0 | 0 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.640099 | 0 | 0 | 0 | 0 |
10 | hsa1813 ( dopamine receptor D2 ) | 0.639775 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5737 ( prostaglandin F receptor ) | 0.822628 | 0 | 0 | 0 | 0 |
2 | hsa5731 ( prostaglandin E receptor 1 ) | 0.771936 | 0 | 0 | 0 | 0 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.749009 | 0 | 0 | 0 | 0 |
4 | hsa5733 ( prostaglandin E receptor 3 ) | 0.742788 | 0 | 0 | 0 | 0 |
5 | hsa4988 ( opioid receptor mu 1 ) | 0.712363 | 0 | 0 | 0 | 0 |
6 | hsa5739 ( prostaglandin I2 (prostacyclin) receptor (IP) ) | 0.678149 | 0 | 0 | 0 | 0 |
7 | hsa1814 ( dopamine receptor D3 ) | 0.659752 | 0 | 0 | 0 | 0 |
8 | hsa5732 ( prostaglandin E receptor 2 ) | 0.646564 | 0 | 0 | 0 | 0 |
9 | hsa2550 ( gamma-aminobutyric acid type B receptor subunit 1 ) | 0.626999 | 0 | 0 | 0 | 0 |
10 | hsa154 ( adrenoceptor beta 2 ) | 0.624816 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5731 ( prostaglandin E receptor 1 ) | 0.915102 | 0 | 0 | 0 | 0 |
2 | hsa5733 ( prostaglandin E receptor 3 ) | 0.903361 | 0 | 0 | 0 | 0 |
3 | hsa5739 ( prostaglandin I2 (prostacyclin) receptor (IP) ) | 0.884795 | 0 | 0 | 0 | 0 |
4 | hsa6915 ( thromboxane A2 receptor ) | 0.86445 | 0 | 0 | 0 | 0 |
5 | hsa5732 ( prostaglandin E receptor 2 ) | 0.834725 | 0 | 0 | 0 | 0 |
6 | hsa4988 ( opioid receptor mu 1 ) | 0.67528 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.665418 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.658127 | 0 | 0 | 0 | 0 |
9 | hsa153 ( adrenoceptor beta 1 ) | 0.634593 | 0 | 0 | 0 | 0 |
10 | hsa64805 ( purinergic receptor P2Y12 ) | 0.62583 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.89645 | 0 | 0 | 0 | 0 |
2 | hsa1813 ( dopamine receptor D2 ) | 0.850079 | 0 | 0 | 0 | 0 |
3 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.843066 | 0 | 0 | 0 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.796716 | 0 | 0 | 0 | 0 |
5 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.782337 | 0 | 0 | 0 | 0 |
6 | hsa1812 ( dopamine receptor D1 ) | 0.779369 | 0 | 0 | 0 | 0 |
7 | hsa59340 ( histamine receptor H4 ) | 0.713572 | 0 | 0 | 0 | 0 |
8 | hsa148 ( adrenoceptor alpha 1A ) | 0.678726 | 0 | 0 | 0 | 0 |
9 | hsa1814 ( dopamine receptor D3 ) | 0.668586 | 0 | 0 | 0 | 0 |
10 | hsa11255 ( histamine receptor H3 ) | 0.66395 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa135 ( adenosine A2a receptor ) | 0.930168 | 1 | 1 | 1 | 0 |
2 | hsa134 ( adenosine A1 receptor ) | 0.929486 | 1 | 1 | 1 | 0 |
3 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.859366 | 0 | 0 | 0 | 0 |
4 | hsa140 ( adenosine A3 receptor ) | 0.858282 | 0 | 0 | 0 | 0 |
5 | hsa185 ( angiotensin II receptor type 1 ) | 0.798431 | 0 | 0 | 0 | 0 |
6 | hsa64805 ( purinergic receptor P2Y12 ) | 0.754838 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.66805 | 0 | 0 | 0 | 0 |
8 | hsa1268 ( cannabinoid receptor 1 ) | 0.64365 | 0 | 0 | 0 | 0 |
9 | hsa153 ( adrenoceptor beta 1 ) | 0.63772 | 0 | 0 | 0 | 0 |
10 | hsa5029 ( purinergic receptor P2Y2 ) | 0.620054 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa185 ( angiotensin II receptor type 1 ) | 0.777497 | 0 | 0 | 0 | 0 |
2 | hsa154 ( adrenoceptor beta 2 ) | 0.669432 | 0 | 0 | 0 | 0 |
3 | hsa153 ( adrenoceptor beta 1 ) | 0.642499 | 0 | 0 | 0 | 0 |
4 | hsa4988 ( opioid receptor mu 1 ) | 0.639675 | 0 | 0 | 0 | 0 |
5 | hsa136 ( adenosine A2b receptor ) | 0.63899 | 0 | 0 | 0 | 0 |
6 | hsa150 ( adrenoceptor alpha 2A ) | 0.638667 | 0 | 0 | 0 | 0 |
7 | hsa134 ( adenosine A1 receptor ) | 0.618168 | 0 | 0 | 0 | 0 |
8 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.597821 | 0 | 0 | 0 | 0 |
9 | hsa222545 ( G protein-coupled receptor class C group 6 member A ) | 0.586693 | 0 | 0 | 0 | 0 |
10 | hsa135 ( adenosine A2a receptor ) | 0.580699 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa185 ( angiotensin II receptor type 1 ) | 0.765925 | 0 | 0 | 0 | 0 |
2 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.722159 | 1 | 0 | 1 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.677759 | 1 | 0 | 1 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.665267 | 1 | 0 | 1 | 0 |
5 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.657047 | 1 | 0 | 1 | 0 |
6 | hsa150 ( adrenoceptor alpha 2A ) | 0.640759 | 1 | 0 | 1 | 0 |
7 | hsa148 ( adrenoceptor alpha 1A ) | 0.616402 | 1 | 0 | 1 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.603719 | 1 | 0 | 1 | 0 |
9 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.592944 | 1 | 0 | 1 | 0 |
10 | hsa153 ( adrenoceptor beta 1 ) | 0.583489 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.965068 | 1 | 1 | 1 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.933411 | 0 | 0 | 0 | 0 |
3 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.896022 | 1 | 1 | 0 | 0 |
4 | hsa154 ( adrenoceptor beta 2 ) | 0.641334 | 0 | 0 | 0 | 0 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.628492 | 0 | 0 | 0 | 0 |
6 | hsa11255 ( histamine receptor H3 ) | 0.597541 | 0 | 0 | 0 | 0 |
7 | hsa153 ( adrenoceptor beta 1 ) | 0.584192 | 0 | 0 | 0 | 0 |
8 | hsa4988 ( opioid receptor mu 1 ) | 0.548745 | 0 | 0 | 0 | 0 |
9 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.544245 | 0 | 0 | 0 | 0 |
10 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.540977 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.853692 | 0 | 0 | 0 | 0 |
2 | hsa4988 ( opioid receptor mu 1 ) | 0.783732 | 0 | 0 | 0 | 0 |
3 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.698926 | 0 | 0 | 0 | 0 |
4 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.661661 | 0 | 0 | 0 | 0 |
5 | hsa148 ( adrenoceptor alpha 1A ) | 0.639264 | 0 | 0 | 0 | 0 |
6 | hsa4986 ( opioid receptor kappa 1 ) | 0.604293 | 0 | 0 | 0 | 0 |
7 | hsa136 ( adenosine A2b receptor ) | 0.583883 | 0 | 0 | 0 | 0 |
8 | hsa64805 ( purinergic receptor P2Y12 ) | 0.578938 | 0 | 0 | 0 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.569285 | 0 | 0 | 0 | 0 |
10 | hsa338442 ( hydroxycarboxylic acid receptor 2 ) | 0.56349 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa185 ( angiotensin II receptor type 1 ) | 0.795048 | 0 | 0 | 0 | 0 |
2 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.678249 | 0 | 0 | 0 | 0 |
3 | hsa4988 ( opioid receptor mu 1 ) | 0.676708 | 0 | 0 | 0 | 0 |
4 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.6181 | 0 | 0 | 0 | 0 |
5 | hsa154 ( adrenoceptor beta 2 ) | 0.612586 | 0 | 0 | 0 | 0 |
6 | hsa3269 ( histamine receptor H1 ) | 0.594848 | 0 | 0 | 0 | 0 |
7 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.589593 | 0 | 0 | 0 | 0 |
8 | hsa153 ( adrenoceptor beta 1 ) | 0.58723 | 0 | 0 | 0 | 0 |
9 | hsa136 ( adenosine A2b receptor ) | 0.586617 | 0 | 0 | 0 | 0 |
10 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.583408 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.800032 | 0 | 0 | 0 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.785203 | 0 | 0 | 0 | 0 |
3 | hsa5729 ( prostaglandin D2 receptor ) | 0.765794 | 0 | 0 | 0 | 0 |
4 | hsa185 ( angiotensin II receptor type 1 ) | 0.738662 | 0 | 0 | 0 | 0 |
5 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.700605 | 0 | 0 | 0 | 0 |
6 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.675188 | 0 | 0 | 0 | 0 |
7 | hsa1813 ( dopamine receptor D2 ) | 0.64238 | 0 | 0 | 0 | 0 |
8 | hsa9283 ( G protein-coupled receptor 37 like 1 ) | 0.625945 | 0 | 0 | 0 | 0 |
9 | hsa4988 ( opioid receptor mu 1 ) | 0.618581 | 0 | 0 | 0 | 0 |
10 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.604998 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.962918 | 1 | 0 | 1 | 0 |
2 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.902729 | 1 | 0 | 1 | 0 |
3 | hsa3354 ( 5-hydroxytryptamine receptor 1E ) | 0.872437 | 0 | 0 | 0 | 0 |
4 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.850707 | 0 | 0 | 0 | 0 |
5 | hsa3361 ( 5-hydroxytryptamine receptor 5A ) | 0.848936 | 0 | 0 | 0 | 0 |
6 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.83967 | 0 | 0 | 0 | 0 |
7 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.827982 | 0 | 0 | 0 | 0 |
8 | hsa148 ( adrenoceptor alpha 1A ) | 0.811233 | 0 | 0 | 0 | 0 |
9 | hsa1814 ( dopamine receptor D3 ) | 0.786562 | 0 | 0 | 0 | 0 |
10 | hsa150 ( adrenoceptor alpha 2A ) | 0.780169 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5731 ( prostaglandin E receptor 1 ) | 0.958706 | 0 | 0 | 0 | 0 |
2 | hsa5737 ( prostaglandin F receptor ) | 0.91429 | 0 | 0 | 0 | 0 |
3 | hsa5739 ( prostaglandin I2 (prostacyclin) receptor (IP) ) | 0.901886 | 0 | 0 | 0 | 0 |
4 | hsa6915 ( thromboxane A2 receptor ) | 0.816608 | 0 | 0 | 0 | 0 |
5 | hsa154 ( adrenoceptor beta 2 ) | 0.685244 | 0 | 0 | 0 | 0 |
6 | hsa153 ( adrenoceptor beta 1 ) | 0.681794 | 0 | 0 | 0 | 0 |
7 | hsa4988 ( opioid receptor mu 1 ) | 0.681214 | 0 | 0 | 0 | 0 |
8 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.648175 | 0 | 0 | 0 | 0 |
9 | hsa5729 ( prostaglandin D2 receptor ) | 0.64656 | 0 | 0 | 0 | 0 |
10 | hsa185 ( angiotensin II receptor type 1 ) | 0.63932 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.842865 | 0 | 0 | 0 | 0 |
2 | hsa153 ( adrenoceptor beta 1 ) | 0.818155 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.733537 | 0 | 0 | 0 | 0 |
4 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.700767 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.700523 | 0 | 0 | 0 | 0 |
6 | hsa155 ( adrenoceptor beta 3 ) | 0.681085 | 0 | 0 | 0 | 0 |
7 | hsa59340 ( histamine receptor H4 ) | 0.679205 | 0 | 0 | 0 | 0 |
8 | hsa136 ( adenosine A2b receptor ) | 0.66449 | 0 | 0 | 0 | 0 |
9 | hsa147 ( adrenoceptor alpha 1B ) | 0.605366 | 0 | 0 | 0 | 0 |
10 | hsa11255 ( histamine receptor H3 ) | 0.59723 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa151 ( adrenoceptor alpha 2B ) | 0.858261 | 1 | 0 | 1 | 1 |
2 | hsa150 ( adrenoceptor alpha 2A ) | 0.844139 | 1 | 0 | 1 | 1 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.832488 | 1 | 1 | 1 | 1 |
4 | hsa3269 ( histamine receptor H1 ) | 0.774612 | 1 | 0 | 1 | 1 |
5 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.762039 | 1 | 0 | 1 | 1 |
6 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.733702 | 1 | 0 | 1 | 0 |
7 | hsa152 ( adrenoceptor alpha 2C ) | 0.702966 | 1 | 0 | 1 | 0 |
8 | hsa1814 ( dopamine receptor D3 ) | 0.702277 | 1 | 0 | 1 | 1 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.694246 | 0 | 0 | 0 | 0 |
10 | hsa3363 ( 5-hydroxytryptamine receptor 7 ) | 0.679785 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa148 ( adrenoceptor alpha 1A ) | 0.771735 | 0 | 0 | 0 | 0 |
2 | hsa3274 ( histamine receptor H2 ) | 0.723263 | 0 | 0 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.663565 | 0 | 0 | 0 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.627863 | 0 | 0 | 0 | 0 |
5 | hsa147 ( adrenoceptor alpha 1B ) | 0.626335 | 0 | 0 | 0 | 0 |
6 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.594971 | 0 | 0 | 0 | 0 |
7 | hsa151 ( adrenoceptor alpha 2B ) | 0.593551 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.549625 | 0 | 0 | 0 | 0 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.525238 | 0 | 0 | 0 | 0 |
10 | hsa3362 ( 5-hydroxytryptamine receptor 6 ) | 0.523978 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa152 ( adrenoceptor alpha 2C ) | 0.868942 | 0 | 0 | 0 | 0 |
2 | hsa3274 ( histamine receptor H2 ) | 0.664496 | 0 | 0 | 0 | 0 |
3 | hsa185 ( angiotensin II receptor type 1 ) | 0.53032 | 0 | 0 | 0 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.525819 | 0 | 0 | 0 | 0 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.501805 | 0 | 0 | 0 | 0 |
6 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.46917 | 0 | 0 | 0 | 0 |
7 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.468036 | 1 | 0 | 0 | 1 |
8 | hsa1812 ( dopamine receptor D1 ) | 0.458001 | 0 | 0 | 0 | 0 |
9 | hsa3269 ( histamine receptor H1 ) | 0.439109 | 0 | 0 | 0 | 0 |
10 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.427525 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.817155 | 0 | 0 | 0 | 0 |
2 | hsa153 ( adrenoceptor beta 1 ) | 0.790415 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.716639 | 0 | 0 | 0 | 0 |
4 | hsa3269 ( histamine receptor H1 ) | 0.714341 | 0 | 0 | 0 | 0 |
5 | hsa59340 ( histamine receptor H4 ) | 0.701929 | 0 | 0 | 0 | 0 |
6 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.69868 | 0 | 0 | 0 | 0 |
7 | hsa136 ( adenosine A2b receptor ) | 0.656059 | 0 | 0 | 0 | 0 |
8 | hsa155 ( adrenoceptor beta 3 ) | 0.646369 | 0 | 0 | 0 | 0 |
9 | hsa11255 ( histamine receptor H3 ) | 0.623727 | 0 | 0 | 0 | 0 |
10 | hsa147 ( adrenoceptor alpha 1B ) | 0.588266 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa6755 ( somatostatin receptor 5 ) | 0.948372 | 1 | 1 | 1 | 0 |
2 | hsa4988 ( opioid receptor mu 1 ) | 0.945831 | 0 | 0 | 0 | 0 |
3 | hsa6753 ( somatostatin receptor 3 ) | 0.928447 | 1 | 1 | 0 | 0 |
4 | hsa4986 ( opioid receptor kappa 1 ) | 0.812426 | 0 | 0 | 0 | 0 |
5 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.737898 | 0 | 0 | 0 | 0 |
6 | hsa185 ( angiotensin II receptor type 1 ) | 0.734752 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.725275 | 0 | 0 | 0 | 0 |
8 | hsa4985 ( opioid receptor delta 1 ) | 0.716939 | 0 | 0 | 0 | 0 |
9 | hsa153 ( adrenoceptor beta 1 ) | 0.689042 | 0 | 0 | 0 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.662373 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.83024 | 0 | 0 | 0 | 0 |
2 | hsa4988 ( opioid receptor mu 1 ) | 0.82642 | 0 | 0 | 0 | 0 |
3 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.70326 | 0 | 0 | 0 | 0 |
4 | hsa4986 ( opioid receptor kappa 1 ) | 0.65459 | 0 | 0 | 0 | 0 |
5 | hsa148 ( adrenoceptor alpha 1A ) | 0.642864 | 0 | 0 | 0 | 0 |
6 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.641935 | 0 | 0 | 0 | 0 |
7 | hsa64805 ( purinergic receptor P2Y12 ) | 0.635513 | 0 | 0 | 0 | 0 |
8 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.608121 | 0 | 0 | 0 | 0 |
9 | hsa136 ( adenosine A2b receptor ) | 0.601893 | 0 | 0 | 0 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.587486 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1814 ( dopamine receptor D3 ) | 0.868519 | 0 | 0 | 0 | 0 |
2 | hsa3363 ( 5-hydroxytryptamine receptor 7 ) | 0.85547 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.835458 | 0 | 0 | 0 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.792786 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.756993 | 0 | 0 | 0 | 0 |
6 | hsa154 ( adrenoceptor beta 2 ) | 0.734112 | 0 | 0 | 0 | 0 |
7 | hsa147 ( adrenoceptor alpha 1B ) | 0.733183 | 0 | 0 | 0 | 0 |
8 | hsa146 ( adrenoceptor alpha 1D ) | 0.727662 | 0 | 0 | 0 | 0 |
9 | hsa153 ( adrenoceptor beta 1 ) | 0.689023 | 0 | 0 | 0 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.668288 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.632484 | 0 | 0 | 0 | 0 |
2 | hsa152 ( adrenoceptor alpha 2C ) | 0.606689 | 1 | 0 | 1 | 0 |
3 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.527373 | 1 | 0 | 1 | 0 |
4 | hsa3274 ( histamine receptor H2 ) | 0.483531 | 1 | 0 | 1 | 0 |
5 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.47904 | 1 | 0 | 1 | 0 |
6 | hsa59340 ( histamine receptor H4 ) | 0.402247 | 1 | 0 | 1 | 0 |
7 | hsa3361 ( 5-hydroxytryptamine receptor 5A ) | 0.334921 | 1 | 0 | 1 | 0 |
8 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.316094 | 0 | 0 | 0 | 0 |
9 | hsa11255 ( histamine receptor H3 ) | 0.303664 | 0 | 0 | 0 | 0 |
10 | hsa3351 ( 5-hydroxytryptamine receptor 1B ) | 0.285238 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.951429 | 1 | 1 | 1 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.920883 | 0 | 0 | 0 | 0 |
3 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.889927 | 0 | 0 | 0 | 0 |
4 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.850752 | 0 | 0 | 0 | 0 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.679341 | 0 | 0 | 0 | 0 |
6 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.609996 | 0 | 0 | 0 | 0 |
7 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.581137 | 0 | 0 | 0 | 0 |
8 | hsa4988 ( opioid receptor mu 1 ) | 0.578969 | 0 | 0 | 0 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.562257 | 0 | 0 | 0 | 0 |
10 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.560539 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.921002 | 1 | 0 | 1 | 1 |
2 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.879786 | 1 | 0 | 1 | 1 |
3 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.832379 | 1 | 0 | 1 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.788511 | 1 | 0 | 1 | 0 |
5 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.709334 | 1 | 0 | 1 | 0 |
6 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.701261 | 1 | 0 | 1 | 0 |
7 | hsa59340 ( histamine receptor H4 ) | 0.698821 | 1 | 0 | 0 | 1 |
8 | hsa1812 ( dopamine receptor D1 ) | 0.693665 | 0 | 0 | 0 | 0 |
9 | hsa11255 ( histamine receptor H3 ) | 0.686621 | 1 | 0 | 0 | 1 |
10 | hsa148 ( adrenoceptor alpha 1A ) | 0.679772 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa148 ( adrenoceptor alpha 1A ) | 0.793554 | 0 | 0 | 0 | 0 |
2 | hsa3274 ( histamine receptor H2 ) | 0.713799 | 0 | 0 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.694074 | 0 | 0 | 0 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.6597 | 0 | 0 | 0 | 0 |
5 | hsa147 ( adrenoceptor alpha 1B ) | 0.659465 | 0 | 0 | 0 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.621623 | 0 | 0 | 0 | 0 |
7 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.591201 | 1 | 0 | 0 | 1 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.547303 | 0 | 0 | 0 | 0 |
9 | hsa3362 ( 5-hydroxytryptamine receptor 6 ) | 0.524805 | 1 | 0 | 0 | 1 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.511961 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.833031 | 0 | 0 | 0 | 0 |
2 | hsa151 ( adrenoceptor alpha 2B ) | 0.76423 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.764044 | 0 | 0 | 0 | 0 |
4 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.760831 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.759111 | 0 | 0 | 0 | 0 |
6 | hsa1815 ( dopamine receptor D4 ) | 0.716291 | 0 | 0 | 0 | 0 |
7 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.708577 | 0 | 0 | 0 | 0 |
8 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.658396 | 0 | 0 | 0 | 0 |
9 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.656956 | 0 | 0 | 0 | 0 |
10 | hsa59340 ( histamine receptor H4 ) | 0.642441 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1812 ( dopamine receptor D1 ) | 0.761883 | 0 | 0 | 0 | 0 |
2 | hsa1815 ( dopamine receptor D4 ) | 0.687341 | 0 | 0 | 0 | 0 |
3 | hsa147 ( adrenoceptor alpha 1B ) | 0.669732 | 0 | 0 | 0 | 0 |
4 | hsa146 ( adrenoceptor alpha 1D ) | 0.660697 | 0 | 0 | 0 | 0 |
5 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.634973 | 0 | 0 | 0 | 0 |
6 | hsa1814 ( dopamine receptor D3 ) | 0.631168 | 0 | 0 | 0 | 0 |
7 | hsa151 ( adrenoceptor alpha 2B ) | 0.520381 | 0 | 0 | 0 | 0 |
8 | hsa1816 ( dopamine receptor D5 ) | 0.502805 | 0 | 0 | 0 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.489272 | 0 | 0 | 0 | 0 |
10 | hsa153 ( adrenoceptor beta 1 ) | 0.476349 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4986 ( opioid receptor kappa 1 ) | 0.928879 | 1 | 1 | 1 | 0 |
2 | hsa4985 ( opioid receptor delta 1 ) | 0.842354 | 0 | 0 | 0 | 0 |
3 | hsa185 ( angiotensin II receptor type 1 ) | 0.793012 | 0 | 0 | 0 | 0 |
4 | hsa6752 ( somatostatin receptor 2 ) | 0.712256 | 0 | 0 | 0 | 0 |
5 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.69011 | 0 | 0 | 0 | 0 |
6 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.666382 | 0 | 0 | 0 | 0 |
7 | hsa6755 ( somatostatin receptor 5 ) | 0.663263 | 0 | 0 | 0 | 0 |
8 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.655593 | 0 | 0 | 0 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.648974 | 0 | 0 | 0 | 0 |
10 | hsa6753 ( somatostatin receptor 3 ) | 0.616431 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa338442 ( hydroxycarboxylic acid receptor 2 ) | 0.821125 | 0 | 0 | 0 | 0 |
2 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.80375 | 0 | 0 | 0 | 0 |
3 | hsa185 ( angiotensin II receptor type 1 ) | 0.759743 | 0 | 0 | 0 | 0 |
4 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.75108 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.722989 | 0 | 0 | 0 | 0 |
6 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.701117 | 0 | 0 | 0 | 0 |
7 | hsa4988 ( opioid receptor mu 1 ) | 0.668882 | 0 | 0 | 0 | 0 |
8 | hsa1813 ( dopamine receptor D2 ) | 0.648303 | 0 | 0 | 0 | 0 |
9 | hsa10800 ( cysteinyl leukotriene receptor 1 ) | 0.626523 | 0 | 0 | 0 | 0 |
10 | hsa57105 ( cysteinyl leukotriene receptor 2 ) | 0.577707 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.923173 | 0 | 0 | 0 | 0 |
2 | hsa147 ( adrenoceptor alpha 1B ) | 0.874118 | 0 | 0 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.868511 | 0 | 0 | 0 | 0 |
4 | hsa1816 ( dopamine receptor D5 ) | 0.851511 | 0 | 0 | 0 | 0 |
5 | hsa151 ( adrenoceptor alpha 2B ) | 0.845397 | 0 | 0 | 0 | 0 |
6 | hsa150 ( adrenoceptor alpha 2A ) | 0.832341 | 0 | 0 | 0 | 0 |
7 | hsa3269 ( histamine receptor H1 ) | 0.830205 | 0 | 0 | 0 | 0 |
8 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.686334 | 0 | 0 | 0 | 0 |
9 | hsa152 ( adrenoceptor alpha 2C ) | 0.665912 | 0 | 0 | 0 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.655289 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.777971 | 1 | 0 | 0 | 1 |
2 | hsa154 ( adrenoceptor beta 2 ) | 0.758215 | 1 | 0 | 0 | 1 |
3 | hsa155 ( adrenoceptor beta 3 ) | 0.674138 | 1 | 0 | 0 | 1 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.648347 | 1 | 0 | 0 | 1 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.621097 | 1 | 0 | 0 | 1 |
6 | hsa3274 ( histamine receptor H2 ) | 0.581155 | 0 | 0 | 0 | 0 |
7 | hsa3269 ( histamine receptor H1 ) | 0.553646 | 1 | 0 | 0 | 1 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.509483 | 0 | 0 | 0 | 0 |
9 | hsa185 ( angiotensin II receptor type 1 ) | 0.501699 | 0 | 0 | 0 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.474753 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa152 ( adrenoceptor alpha 2C ) | 0.828056 | 0 | 0 | 0 | 0 |
2 | hsa3274 ( histamine receptor H2 ) | 0.70862 | 0 | 0 | 0 | 0 |
3 | hsa3363 ( 5-hydroxytryptamine receptor 7 ) | 0.695504 | 0 | 0 | 0 | 0 |
4 | hsa1814 ( dopamine receptor D3 ) | 0.6267 | 0 | 0 | 0 | 0 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.59982 | 0 | 0 | 0 | 0 |
6 | hsa1812 ( dopamine receptor D1 ) | 0.516658 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.49888 | 0 | 0 | 0 | 0 |
8 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.456622 | 0 | 0 | 0 | 0 |
9 | hsa1816 ( dopamine receptor D5 ) | 0.408754 | 0 | 0 | 0 | 0 |
10 | hsa3269 ( histamine receptor H1 ) | 0.405653 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa151 ( adrenoceptor alpha 2B ) | 0.954207 | 1 | 1 | 0 | 0 |
2 | hsa152 ( adrenoceptor alpha 2C ) | 0.945606 | 1 | 1 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.832232 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.829892 | 0 | 0 | 0 | 0 |
5 | hsa147 ( adrenoceptor alpha 1B ) | 0.80828 | 0 | 0 | 0 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.743986 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.67202 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.623135 | 0 | 0 | 0 | 0 |
9 | hsa3269 ( histamine receptor H1 ) | 0.62126 | 0 | 0 | 0 | 0 |
10 | hsa154 ( adrenoceptor beta 2 ) | 0.593274 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.847492 | 0 | 0 | 0 | 0 |
2 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.775697 | 0 | 0 | 0 | 0 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.773001 | 0 | 0 | 0 | 0 |
4 | hsa59340 ( histamine receptor H4 ) | 0.768539 | 1 | 0 | 0 | 1 |
5 | hsa11255 ( histamine receptor H3 ) | 0.751058 | 1 | 0 | 0 | 1 |
6 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.71681 | 0 | 0 | 0 | 0 |
7 | hsa1812 ( dopamine receptor D1 ) | 0.700515 | 0 | 0 | 0 | 0 |
8 | hsa148 ( adrenoceptor alpha 1A ) | 0.650048 | 0 | 0 | 0 | 0 |
9 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.643134 | 0 | 0 | 0 | 0 |
10 | hsa3274 ( histamine receptor H2 ) | 0.588721 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.891539 | 0 | 0 | 0 | 0 |
2 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.841594 | 0 | 0 | 0 | 0 |
3 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.822828 | 0 | 0 | 0 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.758372 | 0 | 0 | 0 | 0 |
5 | hsa59340 ( histamine receptor H4 ) | 0.704221 | 0 | 0 | 0 | 0 |
6 | hsa1812 ( dopamine receptor D1 ) | 0.691017 | 0 | 0 | 0 | 0 |
7 | hsa11255 ( histamine receptor H3 ) | 0.688738 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.6455 | 0 | 0 | 0 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.642051 | 0 | 0 | 0 | 0 |
10 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.626987 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.853921 | 0 | 0 | 0 | 0 |
2 | hsa4988 ( opioid receptor mu 1 ) | 0.805477 | 0 | 0 | 0 | 0 |
3 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.701036 | 0 | 0 | 0 | 0 |
4 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.636353 | 0 | 0 | 0 | 0 |
5 | hsa4986 ( opioid receptor kappa 1 ) | 0.63224 | 0 | 0 | 0 | 0 |
6 | hsa148 ( adrenoceptor alpha 1A ) | 0.618734 | 0 | 0 | 0 | 0 |
7 | hsa64805 ( purinergic receptor P2Y12 ) | 0.617781 | 0 | 0 | 0 | 0 |
8 | hsa136 ( adenosine A2b receptor ) | 0.617336 | 0 | 0 | 0 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.571293 | 0 | 0 | 0 | 0 |
10 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.569736 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.848686 | 0 | 0 | 0 | 0 |
2 | hsa4988 ( opioid receptor mu 1 ) | 0.793444 | 0 | 0 | 0 | 0 |
3 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.683594 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.652116 | 0 | 0 | 0 | 0 |
5 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.648212 | 0 | 0 | 0 | 0 |
6 | hsa4986 ( opioid receptor kappa 1 ) | 0.613156 | 0 | 0 | 0 | 0 |
7 | hsa64805 ( purinergic receptor P2Y12 ) | 0.612528 | 0 | 0 | 0 | 0 |
8 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.593567 | 0 | 0 | 0 | 0 |
9 | hsa136 ( adenosine A2b receptor ) | 0.581532 | 0 | 0 | 0 | 0 |
10 | hsa3269 ( histamine receptor H1 ) | 0.579588 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.902422 | 1 | 1 | 0 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.881591 | 0 | 0 | 0 | 0 |
3 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.836058 | 1 | 1 | 0 | 0 |
4 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.790799 | 1 | 1 | 0 | 0 |
5 | hsa338442 ( hydroxycarboxylic acid receptor 2 ) | 0.683052 | 0 | 0 | 0 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.672273 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.652426 | 0 | 0 | 0 | 0 |
8 | hsa4988 ( opioid receptor mu 1 ) | 0.618667 | 0 | 0 | 0 | 0 |
9 | hsa185 ( angiotensin II receptor type 1 ) | 0.613753 | 0 | 0 | 0 | 0 |
10 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.604022 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.960695 | 1 | 1 | 1 | 0 |
2 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.927896 | 1 | 1 | 1 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.913492 | 0 | 0 | 0 | 0 |
4 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.848023 | 1 | 1 | 0 | 0 |
5 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.803799 | 1 | 1 | 0 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.643579 | 0 | 0 | 0 | 0 |
7 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.60056 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.59953 | 0 | 0 | 0 | 0 |
9 | hsa4988 ( opioid receptor mu 1 ) | 0.597024 | 0 | 0 | 0 | 0 |
10 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.579531 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa185 ( angiotensin II receptor type 1 ) | 0.921133 | 0 | 0 | 0 | 0 |
2 | hsa10800 ( cysteinyl leukotriene receptor 1 ) | 0.760175 | 0 | 0 | 0 | 0 |
3 | hsa222545 ( G protein-coupled receptor class C group 6 member A ) | 0.718787 | 0 | 0 | 0 | 0 |
4 | hsa2550 ( gamma-aminobutyric acid type B receptor subunit 1 ) | 0.696096 | 0 | 0 | 0 | 0 |
5 | hsa5724 ( platelet activating factor receptor ) | 0.689858 | 0 | 0 | 0 | 0 |
6 | hsa57105 ( cysteinyl leukotriene receptor 2 ) | 0.653763 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.611485 | 0 | 0 | 0 | 0 |
8 | hsa5731 ( prostaglandin E receptor 1 ) | 0.599193 | 0 | 0 | 0 | 0 |
9 | hsa4988 ( opioid receptor mu 1 ) | 0.568579 | 0 | 0 | 0 | 0 |
10 | hsa6915 ( thromboxane A2 receptor ) | 0.563599 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.957374 | 1 | 1 | 1 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.927504 | 0 | 0 | 0 | 0 |
3 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.902056 | 0 | 0 | 0 | 0 |
4 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.865204 | 0 | 0 | 0 | 0 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.635752 | 0 | 0 | 0 | 0 |
6 | hsa4988 ( opioid receptor mu 1 ) | 0.587471 | 0 | 0 | 0 | 0 |
7 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.574359 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.563301 | 0 | 0 | 0 | 0 |
9 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.560191 | 0 | 0 | 0 | 0 |
10 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.53958 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa185 ( angiotensin II receptor type 1 ) | 0.780517 | 0 | 0 | 0 | 0 |
2 | hsa154 ( adrenoceptor beta 2 ) | 0.690143 | 0 | 0 | 0 | 0 |
3 | hsa153 ( adrenoceptor beta 1 ) | 0.67656 | 0 | 0 | 0 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.662259 | 0 | 0 | 0 | 0 |
5 | hsa4988 ( opioid receptor mu 1 ) | 0.617413 | 0 | 0 | 0 | 0 |
6 | hsa136 ( adenosine A2b receptor ) | 0.613429 | 0 | 0 | 0 | 0 |
7 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.605237 | 0 | 0 | 0 | 0 |
8 | hsa148 ( adrenoceptor alpha 1A ) | 0.59106 | 0 | 0 | 0 | 0 |
9 | hsa222545 ( G protein-coupled receptor class C group 6 member A ) | 0.582652 | 0 | 0 | 0 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.573471 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1813 ( dopamine receptor D2 ) | 0.966258 | 1 | 1 | 1 | 0 |
2 | hsa1812 ( dopamine receptor D1 ) | 0.949496 | 1 | 0 | 1 | 0 |
3 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.895385 | 1 | 0 | 1 | 0 |
4 | hsa1816 ( dopamine receptor D5 ) | 0.845717 | 1 | 0 | 1 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.790429 | 0 | 0 | 0 | 0 |
6 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.752239 | 1 | 0 | 1 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.708218 | 1 | 0 | 1 | 0 |
8 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.697125 | 0 | 0 | 0 | 0 |
9 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.679934 | 0 | 0 | 0 | 0 |
10 | hsa4985 ( opioid receptor delta 1 ) | 0.671681 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4988 ( opioid receptor mu 1 ) | 0.879989 | 0 | 0 | 0 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.857806 | 0 | 0 | 0 | 0 |
3 | hsa4986 ( opioid receptor kappa 1 ) | 0.846709 | 0 | 0 | 0 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.796905 | 0 | 0 | 0 | 0 |
5 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.65033 | 0 | 0 | 0 | 0 |
6 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.646518 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.616605 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.614318 | 0 | 0 | 0 | 0 |
9 | hsa151 ( adrenoceptor alpha 2B ) | 0.609026 | 0 | 0 | 0 | 0 |
10 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.593008 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1813 ( dopamine receptor D2 ) | 0.899508 | 1 | 0 | 1 | 0 |
2 | hsa146 ( adrenoceptor alpha 1D ) | 0.869692 | 1 | 0 | 1 | 0 |
3 | hsa152 ( adrenoceptor alpha 2C ) | 0.869244 | 1 | 1 | 1 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.854643 | 1 | 0 | 1 | 0 |
5 | hsa147 ( adrenoceptor alpha 1B ) | 0.835786 | 1 | 0 | 1 | 0 |
6 | hsa3269 ( histamine receptor H1 ) | 0.81291 | 1 | 0 | 1 | 1 |
7 | hsa1814 ( dopamine receptor D3 ) | 0.806352 | 1 | 0 | 1 | 0 |
8 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.798636 | 0 | 0 | 0 | 0 |
9 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.773193 | 1 | 0 | 0 | 1 |
10 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.760519 | 1 | 1 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa185 ( angiotensin II receptor type 1 ) | 0.843363 | 0 | 0 | 0 | 0 |
2 | hsa150 ( adrenoceptor alpha 2A ) | 0.668721 | 0 | 0 | 0 | 0 |
3 | hsa4988 ( opioid receptor mu 1 ) | 0.655186 | 0 | 0 | 0 | 0 |
4 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.62851 | 0 | 0 | 0 | 0 |
5 | hsa136 ( adenosine A2b receptor ) | 0.626919 | 0 | 0 | 0 | 0 |
6 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.616874 | 0 | 0 | 0 | 0 |
7 | hsa134 ( adenosine A1 receptor ) | 0.615662 | 0 | 0 | 0 | 0 |
8 | hsa148 ( adrenoceptor alpha 1A ) | 0.611329 | 0 | 0 | 0 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.589805 | 0 | 0 | 0 | 0 |
10 | hsa153 ( adrenoceptor beta 1 ) | 0.583412 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa155 ( adrenoceptor beta 3 ) | 0.936014 | 0 | 0 | 0 | 0 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.726443 | 0 | 0 | 0 | 0 |
3 | hsa3274 ( histamine receptor H2 ) | 0.690512 | 0 | 0 | 0 | 0 |
4 | hsa146 ( adrenoceptor alpha 1D ) | 0.601789 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.600858 | 0 | 0 | 0 | 0 |
6 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.586799 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.58464 | 0 | 0 | 0 | 0 |
8 | hsa147 ( adrenoceptor alpha 1B ) | 0.567903 | 0 | 0 | 0 | 0 |
9 | hsa151 ( adrenoceptor alpha 2B ) | 0.562768 | 0 | 0 | 0 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.536243 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa155 ( adrenoceptor beta 3 ) | 0.929621 | 0 | 0 | 0 | 0 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.707338 | 0 | 0 | 0 | 0 |
3 | hsa3274 ( histamine receptor H2 ) | 0.70716 | 0 | 0 | 0 | 0 |
4 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.593655 | 0 | 0 | 0 | 0 |
5 | hsa146 ( adrenoceptor alpha 1D ) | 0.578331 | 0 | 0 | 0 | 0 |
6 | hsa150 ( adrenoceptor alpha 2A ) | 0.569719 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.564531 | 0 | 0 | 0 | 0 |
8 | hsa147 ( adrenoceptor alpha 1B ) | 0.546312 | 0 | 0 | 0 | 0 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.539594 | 0 | 0 | 0 | 0 |
10 | hsa151 ( adrenoceptor alpha 2B ) | 0.53591 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa148 ( adrenoceptor alpha 1A ) | 0.955942 | 1 | 0 | 1 | 1 |
2 | hsa147 ( adrenoceptor alpha 1B ) | 0.95287 | 1 | 0 | 1 | 1 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.698785 | 0 | 0 | 0 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.690697 | 1 | 0 | 0 | 1 |
5 | hsa153 ( adrenoceptor beta 1 ) | 0.640924 | 0 | 0 | 0 | 0 |
6 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.614739 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.60645 | 0 | 0 | 0 | 0 |
8 | hsa155 ( adrenoceptor beta 3 ) | 0.55249 | 0 | 0 | 0 | 0 |
9 | hsa185 ( angiotensin II receptor type 1 ) | 0.551968 | 0 | 0 | 0 | 0 |
10 | hsa3352 ( 5-hydroxytryptamine receptor 1D ) | 0.525401 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa146 ( adrenoceptor alpha 1D ) | 0.865459 | 0 | 0 | 0 | 0 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.844091 | 0 | 0 | 0 | 0 |
3 | hsa147 ( adrenoceptor alpha 1B ) | 0.836182 | 0 | 0 | 0 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.712396 | 0 | 0 | 0 | 0 |
5 | hsa154 ( adrenoceptor beta 2 ) | 0.662188 | 0 | 0 | 0 | 0 |
6 | hsa153 ( adrenoceptor beta 1 ) | 0.647337 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.616189 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.606543 | 0 | 0 | 0 | 0 |
9 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.567342 | 0 | 0 | 0 | 0 |
10 | hsa155 ( adrenoceptor beta 3 ) | 0.559119 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1813 ( dopamine receptor D2 ) | 0.688675 | 0 | 0 | 0 | 0 |
2 | hsa153 ( adrenoceptor beta 1 ) | 0.667703 | 0 | 0 | 0 | 0 |
3 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.663517 | 0 | 0 | 0 | 0 |
4 | hsa154 ( adrenoceptor beta 2 ) | 0.628366 | 0 | 0 | 0 | 0 |
5 | hsa185 ( angiotensin II receptor type 1 ) | 0.5803 | 0 | 0 | 0 | 0 |
6 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.566175 | 0 | 0 | 0 | 0 |
7 | hsa155 ( adrenoceptor beta 3 ) | 0.55853 | 0 | 0 | 0 | 0 |
8 | hsa3269 ( histamine receptor H1 ) | 0.536266 | 0 | 0 | 0 | 0 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.494879 | 0 | 0 | 0 | 0 |
10 | hsa3274 ( histamine receptor H2 ) | 0.488897 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.6904 | 0 | 0 | 0 | 0 |
2 | hsa153 ( adrenoceptor beta 1 ) | 0.673891 | 1 | 0 | 0 | 1 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.670225 | 0 | 0 | 0 | 0 |
4 | hsa154 ( adrenoceptor beta 2 ) | 0.640767 | 1 | 0 | 0 | 1 |
5 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.581356 | 0 | 0 | 0 | 0 |
6 | hsa155 ( adrenoceptor beta 3 ) | 0.577961 | 1 | 0 | 0 | 1 |
7 | hsa3269 ( histamine receptor H1 ) | 0.573866 | 0 | 0 | 0 | 0 |
8 | hsa185 ( angiotensin II receptor type 1 ) | 0.560037 | 0 | 0 | 0 | 0 |
9 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.543683 | 0 | 0 | 0 | 0 |
10 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.518844 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1813 ( dopamine receptor D2 ) | 0.903161 | 0 | 0 | 0 | 0 |
2 | hsa1814 ( dopamine receptor D3 ) | 0.844023 | 0 | 0 | 0 | 0 |
3 | hsa154 ( adrenoceptor beta 2 ) | 0.826576 | 0 | 0 | 0 | 0 |
4 | hsa153 ( adrenoceptor beta 1 ) | 0.775015 | 0 | 0 | 0 | 0 |
5 | hsa148 ( adrenoceptor alpha 1A ) | 0.764115 | 1 | 0 | 1 | 0 |
6 | hsa146 ( adrenoceptor alpha 1D ) | 0.748246 | 1 | 0 | 1 | 0 |
7 | hsa147 ( adrenoceptor alpha 1B ) | 0.700416 | 1 | 0 | 1 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.659529 | 0 | 0 | 0 | 0 |
9 | hsa155 ( adrenoceptor beta 3 ) | 0.638721 | 0 | 0 | 0 | 0 |
10 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.632874 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.856951 | 0 | 0 | 0 | 0 |
2 | hsa4988 ( opioid receptor mu 1 ) | 0.764359 | 0 | 0 | 0 | 0 |
3 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.686363 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.627099 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.619634 | 0 | 0 | 0 | 0 |
6 | hsa136 ( adenosine A2b receptor ) | 0.617086 | 0 | 0 | 0 | 0 |
7 | hsa64805 ( purinergic receptor P2Y12 ) | 0.612201 | 0 | 0 | 0 | 0 |
8 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.610838 | 0 | 0 | 0 | 0 |
9 | hsa4986 ( opioid receptor kappa 1 ) | 0.589882 | 0 | 0 | 0 | 0 |
10 | hsa134 ( adenosine A1 receptor ) | 0.570617 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa155 ( adrenoceptor beta 3 ) | 0.933105 | 1 | 0 | 0 | 1 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.694219 | 0 | 0 | 0 | 0 |
3 | hsa3274 ( histamine receptor H2 ) | 0.688905 | 0 | 0 | 0 | 0 |
4 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.580191 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.576793 | 0 | 0 | 0 | 0 |
6 | hsa146 ( adrenoceptor alpha 1D ) | 0.570589 | 0 | 0 | 0 | 0 |
7 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.570549 | 0 | 0 | 0 | 0 |
8 | hsa1812 ( dopamine receptor D1 ) | 0.545276 | 0 | 0 | 0 | 0 |
9 | hsa151 ( adrenoceptor alpha 2B ) | 0.54406 | 0 | 0 | 0 | 0 |
10 | hsa147 ( adrenoceptor alpha 1B ) | 0.535582 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa155 ( adrenoceptor beta 3 ) | 0.925632 | 0 | 0 | 0 | 0 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.713984 | 0 | 0 | 0 | 0 |
3 | hsa3274 ( histamine receptor H2 ) | 0.695299 | 0 | 0 | 0 | 0 |
4 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.587992 | 0 | 0 | 0 | 0 |
5 | hsa146 ( adrenoceptor alpha 1D ) | 0.586997 | 0 | 0 | 0 | 0 |
6 | hsa150 ( adrenoceptor alpha 2A ) | 0.586647 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.562681 | 0 | 0 | 0 | 0 |
8 | hsa147 ( adrenoceptor alpha 1B ) | 0.555846 | 0 | 0 | 0 | 0 |
9 | hsa151 ( adrenoceptor alpha 2B ) | 0.548807 | 0 | 0 | 0 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.536859 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa155 ( adrenoceptor beta 3 ) | 0.912654 | 0 | 0 | 0 | 0 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.729678 | 0 | 0 | 0 | 0 |
3 | hsa3274 ( histamine receptor H2 ) | 0.706135 | 0 | 0 | 0 | 0 |
4 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.613789 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.608091 | 0 | 0 | 0 | 0 |
6 | hsa146 ( adrenoceptor alpha 1D ) | 0.599859 | 0 | 0 | 0 | 0 |
7 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.581509 | 0 | 0 | 0 | 0 |
8 | hsa147 ( adrenoceptor alpha 1B ) | 0.573694 | 0 | 0 | 0 | 0 |
9 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.565417 | 0 | 0 | 0 | 0 |
10 | hsa150 ( adrenoceptor alpha 2A ) | 0.557303 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.933085 | 1 | 1 | 1 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.915183 | 0 | 0 | 0 | 0 |
3 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.868583 | 1 | 0 | 1 | 0 |
4 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.824141 | 1 | 0 | 1 | 0 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.708719 | 0 | 0 | 0 | 0 |
6 | hsa154 ( adrenoceptor beta 2 ) | 0.682228 | 0 | 0 | 0 | 0 |
7 | hsa153 ( adrenoceptor beta 1 ) | 0.609409 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.601049 | 0 | 0 | 0 | 0 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.600985 | 0 | 0 | 0 | 0 |
10 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.581593 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.8548 | 0 | 0 | 0 | 0 |
2 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.790272 | 0 | 0 | 0 | 0 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.774311 | 0 | 0 | 0 | 0 |
4 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.722329 | 0 | 0 | 0 | 0 |
5 | hsa1812 ( dopamine receptor D1 ) | 0.707972 | 0 | 0 | 0 | 0 |
6 | hsa59340 ( histamine receptor H4 ) | 0.707267 | 0 | 0 | 0 | 0 |
7 | hsa11255 ( histamine receptor H3 ) | 0.68464 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.665068 | 0 | 0 | 0 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.629175 | 0 | 0 | 0 | 0 |
10 | hsa23620 ( neurotensin receptor 2 ) | 0.594819 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.862692 | 0 | 0 | 0 | 0 |
2 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.797908 | 0 | 0 | 0 | 0 |
3 | hsa59340 ( histamine receptor H4 ) | 0.763744 | 0 | 0 | 0 | 0 |
4 | hsa11255 ( histamine receptor H3 ) | 0.754593 | 0 | 0 | 0 | 0 |
5 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.736104 | 0 | 0 | 0 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.72604 | 0 | 0 | 0 | 0 |
7 | hsa23620 ( neurotensin receptor 2 ) | 0.666441 | 0 | 0 | 0 | 0 |
8 | hsa1812 ( dopamine receptor D1 ) | 0.645641 | 0 | 0 | 0 | 0 |
9 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.628837 | 0 | 0 | 0 | 0 |
10 | hsa148 ( adrenoceptor alpha 1A ) | 0.620517 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.860915 | 0 | 0 | 0 | 0 |
2 | hsa153 ( adrenoceptor beta 1 ) | 0.836698 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.735631 | 0 | 0 | 0 | 0 |
4 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.707041 | 0 | 0 | 0 | 0 |
5 | hsa155 ( adrenoceptor beta 3 ) | 0.705088 | 0 | 0 | 0 | 0 |
6 | hsa3269 ( histamine receptor H1 ) | 0.689883 | 0 | 0 | 0 | 0 |
7 | hsa59340 ( histamine receptor H4 ) | 0.667448 | 0 | 0 | 0 | 0 |
8 | hsa136 ( adenosine A2b receptor ) | 0.651629 | 0 | 0 | 0 | 0 |
9 | hsa147 ( adrenoceptor alpha 1B ) | 0.609979 | 0 | 0 | 0 | 0 |
10 | hsa146 ( adrenoceptor alpha 1D ) | 0.601565 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3351 ( 5-hydroxytryptamine receptor 1B ) | 0.962189 | 1 | 1 | 1 | 1 |
2 | hsa3352 ( 5-hydroxytryptamine receptor 1D ) | 0.962071 | 1 | 1 | 1 | 1 |
3 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.915806 | 1 | 1 | 1 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.914331 | 0 | 0 | 0 | 0 |
5 | hsa3354 ( 5-hydroxytryptamine receptor 1E ) | 0.871943 | 1 | 1 | 0 | 0 |
6 | hsa148 ( adrenoceptor alpha 1A ) | 0.871001 | 0 | 0 | 0 | 0 |
7 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.848679 | 0 | 0 | 0 | 0 |
8 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.843333 | 0 | 0 | 0 | 0 |
9 | hsa1814 ( dopamine receptor D3 ) | 0.832357 | 0 | 0 | 0 | 0 |
10 | hsa3361 ( 5-hydroxytryptamine receptor 5A ) | 0.830402 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.963256 | 1 | 0 | 1 | 0 |
2 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.904425 | 0 | 0 | 0 | 0 |
3 | hsa3354 ( 5-hydroxytryptamine receptor 1E ) | 0.868935 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.850127 | 0 | 0 | 0 | 0 |
5 | hsa3361 ( 5-hydroxytryptamine receptor 5A ) | 0.841225 | 0 | 0 | 0 | 0 |
6 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.825977 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.81632 | 0 | 0 | 0 | 0 |
8 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.815904 | 0 | 0 | 0 | 0 |
9 | hsa1814 ( dopamine receptor D3 ) | 0.803663 | 0 | 0 | 0 | 0 |
10 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.801089 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.911378 | 1 | 0 | 1 | 1 |
2 | hsa3354 ( 5-hydroxytryptamine receptor 1E ) | 0.886108 | 1 | 0 | 0 | 1 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.875553 | 0 | 0 | 0 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.870016 | 1 | 0 | 0 | 1 |
5 | hsa3361 ( 5-hydroxytryptamine receptor 5A ) | 0.855138 | 1 | 0 | 0 | 1 |
6 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.837723 | 1 | 0 | 0 | 1 |
7 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.832197 | 1 | 0 | 0 | 1 |
8 | hsa3363 ( 5-hydroxytryptamine receptor 7 ) | 0.804595 | 0 | 0 | 0 | 0 |
9 | hsa1814 ( dopamine receptor D3 ) | 0.795336 | 0 | 0 | 0 | 0 |
10 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.77633 | 1 | 0 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5739 ( prostaglandin I2 (prostacyclin) receptor (IP) ) | 0.950861 | 0 | 0 | 0 | 0 |
2 | hsa5733 ( prostaglandin E receptor 3 ) | 0.933167 | 0 | 0 | 0 | 0 |
3 | hsa5732 ( prostaglandin E receptor 2 ) | 0.919303 | 0 | 0 | 0 | 0 |
4 | hsa5737 ( prostaglandin F receptor ) | 0.91072 | 1 | 1 | 0 | 0 |
5 | hsa6915 ( thromboxane A2 receptor ) | 0.824597 | 0 | 0 | 0 | 0 |
6 | hsa4988 ( opioid receptor mu 1 ) | 0.726076 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.639891 | 0 | 0 | 0 | 0 |
8 | hsa153 ( adrenoceptor beta 1 ) | 0.635386 | 0 | 0 | 0 | 0 |
9 | hsa64805 ( purinergic receptor P2Y12 ) | 0.624198 | 0 | 0 | 0 | 0 |
10 | hsa3274 ( histamine receptor H2 ) | 0.612436 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.970031 | 1 | 0 | 0 | 1 |
2 | hsa155 ( adrenoceptor beta 3 ) | 0.92092 | 1 | 0 | 0 | 1 |
3 | hsa3274 ( histamine receptor H2 ) | 0.68762 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.68488 | 0 | 0 | 0 | 0 |
5 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.666269 | 0 | 0 | 0 | 0 |
6 | hsa1812 ( dopamine receptor D1 ) | 0.599536 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.584033 | 0 | 0 | 0 | 0 |
8 | hsa146 ( adrenoceptor alpha 1D ) | 0.568562 | 0 | 0 | 0 | 0 |
9 | hsa3269 ( histamine receptor H1 ) | 0.567135 | 0 | 0 | 0 | 0 |
10 | hsa151 ( adrenoceptor alpha 2B ) | 0.549892 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.963452 | 0 | 0 | 0 | 0 |
2 | hsa155 ( adrenoceptor beta 3 ) | 0.909642 | 0 | 0 | 0 | 0 |
3 | hsa3274 ( histamine receptor H2 ) | 0.693473 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.678037 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.656968 | 0 | 0 | 0 | 0 |
6 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.653754 | 0 | 0 | 0 | 0 |
7 | hsa151 ( adrenoceptor alpha 2B ) | 0.614663 | 0 | 0 | 0 | 0 |
8 | hsa1812 ( dopamine receptor D1 ) | 0.606412 | 0 | 0 | 0 | 0 |
9 | hsa3269 ( histamine receptor H1 ) | 0.604003 | 0 | 0 | 0 | 0 |
10 | hsa146 ( adrenoceptor alpha 1D ) | 0.57732 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.966978 | 0 | 0 | 0 | 0 |
2 | hsa155 ( adrenoceptor beta 3 ) | 0.915565 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.719421 | 0 | 0 | 0 | 0 |
4 | hsa3274 ( histamine receptor H2 ) | 0.66866 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.664851 | 0 | 0 | 0 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.631794 | 0 | 0 | 0 | 0 |
7 | hsa146 ( adrenoceptor alpha 1D ) | 0.615008 | 0 | 0 | 0 | 0 |
8 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.603981 | 0 | 0 | 0 | 0 |
9 | hsa147 ( adrenoceptor alpha 1B ) | 0.578119 | 0 | 0 | 0 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.57165 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.969168 | 1 | 0 | 0 | 1 |
2 | hsa155 ( adrenoceptor beta 3 ) | 0.916582 | 1 | 0 | 0 | 1 |
3 | hsa3274 ( histamine receptor H2 ) | 0.706756 | 0 | 0 | 0 | 0 |
4 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.659649 | 0 | 0 | 0 | 0 |
5 | hsa148 ( adrenoceptor alpha 1A ) | 0.657436 | 1 | 0 | 0 | 1 |
6 | hsa1812 ( dopamine receptor D1 ) | 0.59679 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.563508 | 1 | 0 | 0 | 1 |
8 | hsa3269 ( histamine receptor H1 ) | 0.54782 | 0 | 0 | 0 | 0 |
9 | hsa146 ( adrenoceptor alpha 1D ) | 0.536988 | 1 | 0 | 0 | 1 |
10 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.536575 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.970697 | 1 | 1 | 1 | 0 |
2 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.946357 | 1 | 1 | 1 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.910485 | 0 | 0 | 0 | 0 |
4 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.883947 | 1 | 1 | 0 | 0 |
5 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.844804 | 1 | 1 | 0 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.65938 | 0 | 0 | 0 | 0 |
7 | hsa4988 ( opioid receptor mu 1 ) | 0.633845 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.570593 | 0 | 0 | 0 | 0 |
9 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.564866 | 0 | 0 | 0 | 0 |
10 | hsa185 ( angiotensin II receptor type 1 ) | 0.544206 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.83953 | 1 | 0 | 0 | 1 |
2 | hsa3269 ( histamine receptor H1 ) | 0.775923 | 0 | 0 | 0 | 0 |
3 | hsa1812 ( dopamine receptor D1 ) | 0.765997 | 0 | 0 | 0 | 0 |
4 | hsa3363 ( 5-hydroxytryptamine receptor 7 ) | 0.70958 | 0 | 0 | 0 | 0 |
5 | hsa148 ( adrenoceptor alpha 1A ) | 0.708771 | 0 | 0 | 0 | 0 |
6 | hsa154 ( adrenoceptor beta 2 ) | 0.685471 | 0 | 0 | 0 | 0 |
7 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.674309 | 0 | 0 | 0 | 0 |
8 | hsa150 ( adrenoceptor alpha 2A ) | 0.673733 | 0 | 0 | 0 | 0 |
9 | hsa153 ( adrenoceptor beta 1 ) | 0.611148 | 0 | 0 | 0 | 0 |
10 | hsa1815 ( dopamine receptor D4 ) | 0.579572 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.977996 | 0 | 0 | 0 | 0 |
2 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.943992 | 0 | 0 | 0 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.876742 | 0 | 0 | 0 | 0 |
4 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.873866 | 0 | 0 | 0 | 0 |
5 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.824921 | 0 | 0 | 0 | 0 |
6 | hsa4988 ( opioid receptor mu 1 ) | 0.613125 | 0 | 0 | 0 | 0 |
7 | hsa1813 ( dopamine receptor D2 ) | 0.603983 | 0 | 0 | 0 | 0 |
8 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.582798 | 0 | 0 | 0 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.571429 | 0 | 0 | 0 | 0 |
10 | hsa154 ( adrenoceptor beta 2 ) | 0.563276 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.976455 | 0 | 0 | 0 | 0 |
2 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.940005 | 0 | 0 | 0 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.902971 | 0 | 0 | 0 | 0 |
4 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.863937 | 0 | 0 | 0 | 0 |
5 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.814258 | 0 | 0 | 0 | 0 |
6 | hsa4988 ( opioid receptor mu 1 ) | 0.624487 | 0 | 0 | 0 | 0 |
7 | hsa185 ( angiotensin II receptor type 1 ) | 0.595638 | 0 | 0 | 0 | 0 |
8 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.582784 | 0 | 0 | 0 | 0 |
9 | hsa1813 ( dopamine receptor D2 ) | 0.569966 | 0 | 0 | 0 | 0 |
10 | hsa154 ( adrenoceptor beta 2 ) | 0.564927 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.699656 | 0 | 0 | 0 | 0 |
2 | hsa185 ( angiotensin II receptor type 1 ) | 0.68733 | 0 | 0 | 0 | 0 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.686567 | 0 | 0 | 0 | 0 |
4 | hsa3269 ( histamine receptor H1 ) | 0.685414 | 0 | 0 | 0 | 0 |
5 | hsa4988 ( opioid receptor mu 1 ) | 0.65682 | 0 | 0 | 0 | 0 |
6 | hsa1812 ( dopamine receptor D1 ) | 0.654745 | 0 | 0 | 0 | 0 |
7 | hsa136 ( adenosine A2b receptor ) | 0.650757 | 0 | 0 | 0 | 0 |
8 | hsa134 ( adenosine A1 receptor ) | 0.650416 | 0 | 0 | 0 | 0 |
9 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.636781 | 0 | 0 | 0 | 0 |
10 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.633911 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa222545 ( G protein-coupled receptor class C group 6 member A ) | 0.87327 | 0 | 0 | 0 | 0 |
2 | hsa154 ( adrenoceptor beta 2 ) | 0.716993 | 0 | 0 | 0 | 0 |
3 | hsa153 ( adrenoceptor beta 1 ) | 0.658076 | 0 | 0 | 0 | 0 |
4 | hsa3352 ( 5-hydroxytryptamine receptor 1D ) | 0.625812 | 0 | 0 | 0 | 0 |
5 | hsa2550 ( gamma-aminobutyric acid type B receptor subunit 1 ) | 0.621246 | 0 | 0 | 0 | 0 |
6 | hsa3351 ( 5-hydroxytryptamine receptor 1B ) | 0.620787 | 0 | 0 | 0 | 0 |
7 | hsa6010 ( rhodopsin ) | 0.606558 | 0 | 0 | 0 | 0 |
8 | hsa3269 ( histamine receptor H1 ) | 0.599893 | 0 | 0 | 0 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.598775 | 0 | 0 | 0 | 0 |
10 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.595237 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.951412 | 1 | 1 | 0 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.908781 | 0 | 0 | 0 | 0 |
3 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.893401 | 1 | 1 | 0 | 0 |
4 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.852485 | 1 | 1 | 0 | 0 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.646072 | 0 | 0 | 0 | 0 |
6 | hsa4988 ( opioid receptor mu 1 ) | 0.625053 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.591949 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.559048 | 0 | 0 | 0 | 0 |
9 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.552503 | 0 | 0 | 0 | 0 |
10 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.546753 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1814 ( dopamine receptor D3 ) | 0.923169 | 1 | 0 | 1 | 0 |
2 | hsa1812 ( dopamine receptor D1 ) | 0.914963 | 1 | 0 | 1 | 0 |
3 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.854911 | 1 | 0 | 1 | 0 |
4 | hsa3269 ( histamine receptor H1 ) | 0.77611 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.771526 | 1 | 0 | 1 | 0 |
6 | hsa1816 ( dopamine receptor D5 ) | 0.754706 | 1 | 0 | 1 | 0 |
7 | hsa151 ( adrenoceptor alpha 2B ) | 0.743034 | 1 | 0 | 1 | 0 |
8 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.722793 | 0 | 0 | 0 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.716963 | 1 | 0 | 1 | 0 |
10 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.635232 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1814 ( dopamine receptor D3 ) | 0.943023 | 1 | 0 | 1 | 0 |
2 | hsa1816 ( dopamine receptor D5 ) | 0.885294 | 0 | 0 | 0 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.873708 | 1 | 0 | 1 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.865398 | 1 | 0 | 1 | 0 |
5 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.747855 | 1 | 0 | 1 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.723079 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.722739 | 0 | 0 | 0 | 0 |
8 | hsa148 ( adrenoceptor alpha 1A ) | 0.718386 | 0 | 0 | 0 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.680246 | 0 | 0 | 0 | 0 |
10 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.650973 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4985 ( opioid receptor delta 1 ) | 0.905627 | 1 | 0 | 1 | 0 |
2 | hsa185 ( angiotensin II receptor type 1 ) | 0.812587 | 0 | 0 | 0 | 0 |
3 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.788204 | 0 | 0 | 0 | 0 |
4 | hsa6752 ( somatostatin receptor 2 ) | 0.712584 | 0 | 0 | 0 | 0 |
5 | hsa1812 ( dopamine receptor D1 ) | 0.701032 | 0 | 0 | 0 | 0 |
6 | hsa6755 ( somatostatin receptor 5 ) | 0.696689 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.668931 | 0 | 0 | 0 | 0 |
8 | hsa6753 ( somatostatin receptor 3 ) | 0.651669 | 0 | 0 | 0 | 0 |
9 | hsa1814 ( dopamine receptor D3 ) | 0.635285 | 0 | 0 | 0 | 0 |
10 | hsa154 ( adrenoceptor beta 2 ) | 0.628804 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4985 ( opioid receptor delta 1 ) | 0.912646 | 1 | 1 | 0 | 0 |
2 | hsa185 ( angiotensin II receptor type 1 ) | 0.811835 | 0 | 0 | 0 | 0 |
3 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.759242 | 0 | 0 | 0 | 0 |
4 | hsa6752 ( somatostatin receptor 2 ) | 0.742946 | 0 | 0 | 0 | 0 |
5 | hsa6755 ( somatostatin receptor 5 ) | 0.716465 | 0 | 0 | 0 | 0 |
6 | hsa1812 ( dopamine receptor D1 ) | 0.715989 | 0 | 0 | 0 | 0 |
7 | hsa6753 ( somatostatin receptor 3 ) | 0.674666 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.656739 | 0 | 0 | 0 | 0 |
9 | hsa1814 ( dopamine receptor D3 ) | 0.654708 | 0 | 0 | 0 | 0 |
10 | hsa6751 ( somatostatin receptor 1 ) | 0.633151 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4986 ( opioid receptor kappa 1 ) | 0.920279 | 1 | 0 | 1 | 0 |
2 | hsa4985 ( opioid receptor delta 1 ) | 0.831269 | 1 | 0 | 1 | 0 |
3 | hsa185 ( angiotensin II receptor type 1 ) | 0.795161 | 0 | 0 | 0 | 0 |
4 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.738616 | 0 | 0 | 0 | 0 |
5 | hsa6752 ( somatostatin receptor 2 ) | 0.696296 | 0 | 0 | 0 | 0 |
6 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.690536 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.689729 | 0 | 0 | 0 | 0 |
8 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.682195 | 0 | 0 | 0 | 0 |
9 | hsa6755 ( somatostatin receptor 5 ) | 0.650575 | 0 | 0 | 0 | 0 |
10 | hsa3269 ( histamine receptor H1 ) | 0.650007 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa147 ( adrenoceptor alpha 1B ) | 0.934703 | 0 | 0 | 0 | 0 |
2 | hsa146 ( adrenoceptor alpha 1D ) | 0.924854 | 0 | 0 | 0 | 0 |
3 | hsa153 ( adrenoceptor beta 1 ) | 0.756858 | 0 | 0 | 0 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.742522 | 0 | 0 | 0 | 0 |
5 | hsa151 ( adrenoceptor alpha 2B ) | 0.739879 | 0 | 0 | 0 | 0 |
6 | hsa154 ( adrenoceptor beta 2 ) | 0.699726 | 0 | 0 | 0 | 0 |
7 | hsa3269 ( histamine receptor H1 ) | 0.696951 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.680626 | 0 | 0 | 0 | 0 |
9 | hsa185 ( angiotensin II receptor type 1 ) | 0.679286 | 0 | 0 | 0 | 0 |
10 | hsa3274 ( histamine receptor H2 ) | 0.660071 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa147 ( adrenoceptor alpha 1B ) | 0.947205 | 0 | 0 | 0 | 0 |
2 | hsa146 ( adrenoceptor alpha 1D ) | 0.943256 | 0 | 0 | 0 | 0 |
3 | hsa153 ( adrenoceptor beta 1 ) | 0.835199 | 0 | 0 | 0 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.802961 | 0 | 0 | 0 | 0 |
5 | hsa151 ( adrenoceptor alpha 2B ) | 0.797979 | 0 | 0 | 0 | 0 |
6 | hsa154 ( adrenoceptor beta 2 ) | 0.794328 | 0 | 0 | 0 | 0 |
7 | hsa3274 ( histamine receptor H2 ) | 0.738877 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.708715 | 0 | 0 | 0 | 0 |
9 | hsa155 ( adrenoceptor beta 3 ) | 0.705628 | 0 | 0 | 0 | 0 |
10 | hsa152 ( adrenoceptor alpha 2C ) | 0.69616 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1814 ( dopamine receptor D3 ) | 0.921395 | 1 | 0 | 1 | 0 |
2 | hsa1812 ( dopamine receptor D1 ) | 0.900466 | 1 | 0 | 1 | 0 |
3 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.884298 | 1 | 0 | 1 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.797596 | 1 | 0 | 1 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.769183 | 0 | 0 | 0 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.76531 | 1 | 0 | 1 | 0 |
7 | hsa148 ( adrenoceptor alpha 1A ) | 0.759873 | 1 | 0 | 1 | 0 |
8 | hsa1816 ( dopamine receptor D5 ) | 0.732298 | 1 | 0 | 1 | 0 |
9 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.696953 | 1 | 0 | 1 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.687898 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3274 ( histamine receptor H2 ) | 0.620536 | 0 | 0 | 0 | 0 |
2 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.563099 | 0 | 0 | 0 | 0 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.483776 | 0 | 0 | 0 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.482902 | 0 | 0 | 0 | 0 |
5 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.428238 | 0 | 0 | 0 | 0 |
6 | hsa1812 ( dopamine receptor D1 ) | 0.418888 | 0 | 0 | 0 | 0 |
7 | hsa185 ( angiotensin II receptor type 1 ) | 0.40996 | 0 | 0 | 0 | 0 |
8 | hsa3269 ( histamine receptor H1 ) | 0.407292 | 0 | 0 | 0 | 0 |
9 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.404272 | 0 | 0 | 0 | 0 |
10 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.396784 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.889926 | 0 | 0 | 0 | 0 |
2 | hsa154 ( adrenoceptor beta 2 ) | 0.869782 | 0 | 0 | 0 | 0 |
3 | hsa151 ( adrenoceptor alpha 2B ) | 0.86937 | 0 | 0 | 0 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.868567 | 0 | 0 | 0 | 0 |
5 | hsa155 ( adrenoceptor beta 3 ) | 0.802633 | 0 | 0 | 0 | 0 |
6 | hsa152 ( adrenoceptor alpha 2C ) | 0.794251 | 0 | 0 | 0 | 0 |
7 | hsa3274 ( histamine receptor H2 ) | 0.687241 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.661762 | 0 | 0 | 0 | 0 |
9 | hsa3269 ( histamine receptor H1 ) | 0.57058 | 0 | 0 | 0 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.551476 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.768873 | 0 | 0 | 0 | 0 |
2 | hsa154 ( adrenoceptor beta 2 ) | 0.736524 | 0 | 0 | 0 | 0 |
3 | hsa155 ( adrenoceptor beta 3 ) | 0.676959 | 0 | 0 | 0 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.640957 | 0 | 0 | 0 | 0 |
5 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.614079 | 0 | 0 | 0 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.607076 | 0 | 0 | 0 | 0 |
7 | hsa185 ( angiotensin II receptor type 1 ) | 0.579179 | 0 | 0 | 0 | 0 |
8 | hsa3274 ( histamine receptor H2 ) | 0.563501 | 0 | 0 | 0 | 0 |
9 | hsa3363 ( 5-hydroxytryptamine receptor 7 ) | 0.468885 | 0 | 0 | 0 | 0 |
10 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.464976 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa151 ( adrenoceptor alpha 2B ) | 0.861613 | 0 | 0 | 0 | 0 |
2 | hsa150 ( adrenoceptor alpha 2A ) | 0.849721 | 0 | 0 | 0 | 0 |
3 | hsa152 ( adrenoceptor alpha 2C ) | 0.765875 | 0 | 0 | 0 | 0 |
4 | hsa3269 ( histamine receptor H1 ) | 0.759001 | 0 | 0 | 0 | 0 |
5 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.75097 | 0 | 0 | 0 | 0 |
6 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.723176 | 0 | 0 | 0 | 0 |
7 | hsa153 ( adrenoceptor beta 1 ) | 0.721165 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.674254 | 0 | 0 | 0 | 0 |
9 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.656262 | 0 | 0 | 0 | 0 |
10 | hsa3274 ( histamine receptor H2 ) | 0.6412 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa150 ( adrenoceptor alpha 2A ) | 0.8861 | 0 | 0 | 0 | 0 |
2 | hsa151 ( adrenoceptor alpha 2B ) | 0.873809 | 0 | 0 | 0 | 0 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.863074 | 1 | 1 | 0 | 0 |
4 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.862814 | 0 | 0 | 0 | 0 |
5 | hsa3351 ( 5-hydroxytryptamine receptor 1B ) | 0.818818 | 0 | 0 | 0 | 0 |
6 | hsa3352 ( 5-hydroxytryptamine receptor 1D ) | 0.805534 | 0 | 0 | 0 | 0 |
7 | hsa1814 ( dopamine receptor D3 ) | 0.805388 | 0 | 0 | 0 | 0 |
8 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.797451 | 0 | 0 | 0 | 0 |
9 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.793748 | 0 | 0 | 0 | 0 |
10 | hsa152 ( adrenoceptor alpha 2C ) | 0.775713 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa185 ( angiotensin II receptor type 1 ) | 0.833094 | 0 | 0 | 0 | 0 |
2 | hsa4988 ( opioid receptor mu 1 ) | 0.6678 | 0 | 0 | 0 | 0 |
3 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.642007 | 0 | 0 | 0 | 0 |
4 | hsa154 ( adrenoceptor beta 2 ) | 0.628665 | 0 | 0 | 0 | 0 |
5 | hsa136 ( adenosine A2b receptor ) | 0.626297 | 0 | 0 | 0 | 0 |
6 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.619061 | 0 | 0 | 0 | 0 |
7 | hsa153 ( adrenoceptor beta 1 ) | 0.618093 | 0 | 0 | 0 | 0 |
8 | hsa134 ( adenosine A1 receptor ) | 0.599919 | 0 | 0 | 0 | 0 |
9 | hsa150 ( adrenoceptor alpha 2A ) | 0.595193 | 0 | 0 | 0 | 0 |
10 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.587579 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.973383 | 1 | 1 | 0 | 1 |
2 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.952886 | 1 | 1 | 0 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.905465 | 0 | 0 | 0 | 0 |
4 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.890166 | 1 | 1 | 0 | 0 |
5 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.849949 | 1 | 1 | 0 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.609023 | 0 | 0 | 0 | 0 |
7 | hsa4988 ( opioid receptor mu 1 ) | 0.586773 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.583119 | 0 | 0 | 0 | 0 |
9 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.559448 | 0 | 0 | 0 | 0 |
10 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.557749 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.960795 | 1 | 1 | 1 | 0 |
2 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.931172 | 1 | 1 | 0 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.923565 | 0 | 0 | 0 | 0 |
4 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.86275 | 1 | 1 | 0 | 0 |
5 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.822739 | 1 | 1 | 0 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.736869 | 0 | 0 | 0 | 0 |
7 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.65479 | 0 | 0 | 0 | 0 |
8 | hsa148 ( adrenoceptor alpha 1A ) | 0.609389 | 0 | 0 | 0 | 0 |
9 | hsa11255 ( histamine receptor H3 ) | 0.577588 | 0 | 0 | 0 | 0 |
10 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.56913 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.762056 | 0 | 0 | 0 | 0 |
2 | hsa2918 ( glutamate metabotropic receptor 8 ) | 0.678176 | 0 | 0 | 0 | 0 |
3 | hsa185 ( angiotensin II receptor type 1 ) | 0.669887 | 0 | 0 | 0 | 0 |
4 | hsa154 ( adrenoceptor beta 2 ) | 0.649546 | 0 | 0 | 0 | 0 |
5 | hsa2550 ( gamma-aminobutyric acid type B receptor subunit 1 ) | 0.640651 | 0 | 0 | 0 | 0 |
6 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.615873 | 0 | 0 | 0 | 0 |
7 | hsa148 ( adrenoceptor alpha 1A ) | 0.605075 | 0 | 0 | 0 | 0 |
8 | hsa150 ( adrenoceptor alpha 2A ) | 0.604692 | 0 | 0 | 0 | 0 |
9 | hsa3274 ( histamine receptor H2 ) | 0.604389 | 0 | 0 | 0 | 0 |
10 | hsa153 ( adrenoceptor beta 1 ) | 0.601067 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1812 ( dopamine receptor D1 ) | 0.928113 | 1 | 0 | 1 | 0 |
2 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.859002 | 0 | 0 | 0 | 0 |
3 | hsa3351 ( 5-hydroxytryptamine receptor 1B ) | 0.84571 | 1 | 0 | 1 | 0 |
4 | hsa3352 ( 5-hydroxytryptamine receptor 1D ) | 0.837384 | 1 | 0 | 1 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.829092 | 1 | 0 | 1 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.788604 | 1 | 0 | 1 | 0 |
7 | hsa3269 ( histamine receptor H1 ) | 0.77496 | 1 | 0 | 1 | 0 |
8 | hsa1816 ( dopamine receptor D5 ) | 0.774782 | 1 | 0 | 1 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.765827 | 1 | 0 | 1 | 0 |
10 | hsa3361 ( 5-hydroxytryptamine receptor 5A ) | 0.764548 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3269 ( histamine receptor H1 ) | 0.766246 | 0 | 0 | 0 | 0 |
2 | hsa185 ( angiotensin II receptor type 1 ) | 0.710853 | 0 | 0 | 0 | 0 |
3 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.698092 | 0 | 0 | 0 | 0 |
4 | hsa4988 ( opioid receptor mu 1 ) | 0.666204 | 0 | 0 | 0 | 0 |
5 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.614188 | 0 | 0 | 0 | 0 |
6 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.613384 | 0 | 0 | 0 | 0 |
7 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.606784 | 0 | 0 | 0 | 0 |
8 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.60669 | 0 | 0 | 0 | 0 |
9 | hsa5724 ( platelet activating factor receptor ) | 0.606295 | 0 | 0 | 0 | 0 |
10 | hsa3274 ( histamine receptor H2 ) | 0.598436 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.742888 | 0 | 0 | 0 | 0 |
2 | hsa185 ( angiotensin II receptor type 1 ) | 0.730347 | 0 | 0 | 0 | 0 |
3 | hsa4988 ( opioid receptor mu 1 ) | 0.724341 | 0 | 0 | 0 | 0 |
4 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.701949 | 0 | 0 | 0 | 0 |
5 | hsa3274 ( histamine receptor H2 ) | 0.699818 | 0 | 0 | 0 | 0 |
6 | hsa153 ( adrenoceptor beta 1 ) | 0.680518 | 0 | 0 | 0 | 0 |
7 | hsa222545 ( G protein-coupled receptor class C group 6 member A ) | 0.676864 | 0 | 0 | 0 | 0 |
8 | hsa1813 ( dopamine receptor D2 ) | 0.619923 | 0 | 0 | 0 | 0 |
9 | hsa4986 ( opioid receptor kappa 1 ) | 0.589258 | 0 | 0 | 0 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.578293 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.899522 | 1 | 0 | 1 | 1 |
2 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.849584 | 1 | 0 | 1 | 1 |
3 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.807353 | 1 | 0 | 1 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.753303 | 1 | 0 | 1 | 0 |
5 | hsa59340 ( histamine receptor H4 ) | 0.738237 | 1 | 0 | 0 | 1 |
6 | hsa11255 ( histamine receptor H3 ) | 0.726994 | 1 | 0 | 0 | 1 |
7 | hsa148 ( adrenoceptor alpha 1A ) | 0.670856 | 1 | 0 | 1 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.665423 | 1 | 0 | 1 | 0 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.65804 | 0 | 0 | 0 | 0 |
10 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.645289 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.96731 | 1 | 0 | 1 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.939992 | 0 | 0 | 0 | 0 |
3 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.936917 | 1 | 1 | 1 | 0 |
4 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.866762 | 1 | 0 | 1 | 0 |
5 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.824981 | 1 | 0 | 1 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.638544 | 0 | 0 | 0 | 0 |
7 | hsa11255 ( histamine receptor H3 ) | 0.61553 | 0 | 0 | 0 | 0 |
8 | hsa4988 ( opioid receptor mu 1 ) | 0.576294 | 0 | 0 | 0 | 0 |
9 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.560292 | 0 | 0 | 0 | 0 |
10 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.555832 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.847495 | 0 | 0 | 0 | 0 |
2 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.801234 | 1 | 0 | 1 | 0 |
3 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.710925 | 1 | 0 | 1 | 0 |
4 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.704307 | 0 | 0 | 0 | 0 |
5 | hsa4985 ( opioid receptor delta 1 ) | 0.661004 | 0 | 0 | 0 | 0 |
6 | hsa154 ( adrenoceptor beta 2 ) | 0.654253 | 0 | 0 | 0 | 0 |
7 | hsa148 ( adrenoceptor alpha 1A ) | 0.64478 | 0 | 0 | 0 | 0 |
8 | hsa4988 ( opioid receptor mu 1 ) | 0.637285 | 0 | 0 | 0 | 0 |
9 | hsa151 ( adrenoceptor alpha 2B ) | 0.635336 | 0 | 0 | 0 | 0 |
10 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.629288 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.957124 | 0 | 0 | 0 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.929326 | 0 | 0 | 0 | 0 |
3 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.917792 | 0 | 0 | 0 | 0 |
4 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.851067 | 0 | 0 | 0 | 0 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.811203 | 0 | 0 | 0 | 0 |
6 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.810383 | 0 | 0 | 0 | 0 |
7 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.783838 | 0 | 0 | 0 | 0 |
8 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.669098 | 0 | 0 | 0 | 0 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.65624 | 0 | 0 | 0 | 0 |
10 | hsa148 ( adrenoceptor alpha 1A ) | 0.646945 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.873071 | 0 | 0 | 0 | 0 |
2 | hsa1813 ( dopamine receptor D2 ) | 0.828894 | 0 | 0 | 0 | 0 |
3 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.813313 | 0 | 0 | 0 | 0 |
4 | hsa1812 ( dopamine receptor D1 ) | 0.768141 | 0 | 0 | 0 | 0 |
5 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.762775 | 0 | 0 | 0 | 0 |
6 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.746805 | 0 | 0 | 0 | 0 |
7 | hsa59340 ( histamine receptor H4 ) | 0.718036 | 0 | 0 | 0 | 0 |
8 | hsa11255 ( histamine receptor H3 ) | 0.685342 | 0 | 0 | 0 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.655898 | 0 | 0 | 0 | 0 |
10 | hsa1814 ( dopamine receptor D3 ) | 0.643222 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.876814 | 0 | 0 | 0 | 0 |
2 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.816596 | 0 | 0 | 0 | 0 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.776793 | 0 | 0 | 0 | 0 |
4 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.760198 | 0 | 0 | 0 | 0 |
5 | hsa59340 ( histamine receptor H4 ) | 0.732886 | 0 | 0 | 0 | 0 |
6 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.719332 | 0 | 0 | 0 | 0 |
7 | hsa11255 ( histamine receptor H3 ) | 0.699823 | 0 | 0 | 0 | 0 |
8 | hsa1812 ( dopamine receptor D1 ) | 0.69023 | 0 | 0 | 0 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.670673 | 0 | 0 | 0 | 0 |
10 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.600307 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2913 ( glutamate metabotropic receptor 3 ) | 0.904283 | 0 | 0 | 0 | 0 |
2 | hsa2916 ( glutamate metabotropic receptor 6 ) | 0.897619 | 0 | 0 | 0 | 0 |
3 | hsa2912 ( glutamate metabotropic receptor 2 ) | 0.892631 | 0 | 0 | 0 | 0 |
4 | hsa2914 ( glutamate metabotropic receptor 4 ) | 0.833576 | 0 | 0 | 0 | 0 |
5 | hsa2917 ( glutamate metabotropic receptor 7 ) | 0.826392 | 0 | 0 | 0 | 0 |
6 | hsa3269 ( histamine receptor H1 ) | 0.792942 | 0 | 0 | 0 | 0 |
7 | hsa222545 ( G protein-coupled receptor class C group 6 member A ) | 0.751659 | 0 | 0 | 0 | 0 |
8 | hsa2911 ( glutamate metabotropic receptor 1 ) | 0.735081 | 0 | 0 | 0 | 0 |
9 | hsa2915 ( glutamate metabotropic receptor 5 ) | 0.725403 | 0 | 0 | 0 | 0 |
10 | hsa4988 ( opioid receptor mu 1 ) | 0.694157 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5731 ( prostaglandin E receptor 1 ) | 0.963145 | 0 | 0 | 0 | 0 |
2 | hsa5733 ( prostaglandin E receptor 3 ) | 0.890986 | 0 | 0 | 0 | 0 |
3 | hsa5732 ( prostaglandin E receptor 2 ) | 0.890153 | 0 | 0 | 0 | 0 |
4 | hsa6915 ( thromboxane A2 receptor ) | 0.858476 | 0 | 0 | 0 | 0 |
5 | hsa64805 ( purinergic receptor P2Y12 ) | 0.735477 | 0 | 0 | 0 | 0 |
6 | hsa154 ( adrenoceptor beta 2 ) | 0.664232 | 0 | 0 | 0 | 0 |
7 | hsa4988 ( opioid receptor mu 1 ) | 0.654624 | 0 | 0 | 0 | 0 |
8 | hsa153 ( adrenoceptor beta 1 ) | 0.644453 | 0 | 0 | 0 | 0 |
9 | hsa5729 ( prostaglandin D2 receptor ) | 0.61173 | 0 | 0 | 0 | 0 |
10 | hsa3269 ( histamine receptor H1 ) | 0.596686 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa151 ( adrenoceptor alpha 2B ) | 0.887438 | 1 | 1 | 0 | 0 |
2 | hsa150 ( adrenoceptor alpha 2A ) | 0.871945 | 1 | 1 | 0 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.800501 | 1 | 0 | 0 | 1 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.774501 | 1 | 0 | 0 | 1 |
5 | hsa152 ( adrenoceptor alpha 2C ) | 0.757171 | 1 | 1 | 0 | 0 |
6 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.755962 | 1 | 1 | 0 | 1 |
7 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.737958 | 0 | 0 | 0 | 0 |
8 | hsa153 ( adrenoceptor beta 1 ) | 0.673515 | 1 | 0 | 0 | 1 |
9 | hsa3274 ( histamine receptor H2 ) | 0.662934 | 0 | 0 | 0 | 0 |
10 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.662827 | 1 | 1 | 0 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.967098 | 1 | 1 | 0 | 0 |
2 | hsa155 ( adrenoceptor beta 3 ) | 0.917892 | 1 | 1 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.749948 | 1 | 1 | 0 | 0 |
4 | hsa3274 ( histamine receptor H2 ) | 0.668107 | 0 | 0 | 0 | 0 |
5 | hsa146 ( adrenoceptor alpha 1D ) | 0.653508 | 1 | 1 | 0 | 0 |
6 | hsa150 ( adrenoceptor alpha 2A ) | 0.650215 | 1 | 1 | 0 | 0 |
7 | hsa151 ( adrenoceptor alpha 2B ) | 0.62088 | 1 | 1 | 0 | 0 |
8 | hsa147 ( adrenoceptor alpha 1B ) | 0.620743 | 1 | 1 | 0 | 0 |
9 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.601842 | 0 | 0 | 0 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.569061 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa148 ( adrenoceptor alpha 1A ) | 0.772334 | 0 | 0 | 0 | 0 |
2 | hsa3274 ( histamine receptor H2 ) | 0.727913 | 0 | 0 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.667414 | 0 | 0 | 0 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.648736 | 0 | 0 | 0 | 0 |
5 | hsa147 ( adrenoceptor alpha 1B ) | 0.630251 | 0 | 0 | 0 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.614376 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.551931 | 0 | 0 | 0 | 0 |
8 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.543908 | 0 | 0 | 0 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.513777 | 1 | 0 | 0 | 1 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.510021 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3269 ( histamine receptor H1 ) | 0.818763 | 0 | 0 | 0 | 0 |
2 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.717551 | 0 | 0 | 0 | 0 |
3 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.709742 | 0 | 0 | 0 | 0 |
4 | hsa185 ( angiotensin II receptor type 1 ) | 0.68796 | 0 | 0 | 0 | 0 |
5 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.641779 | 0 | 0 | 0 | 0 |
6 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.64021 | 0 | 0 | 0 | 0 |
7 | hsa10800 ( cysteinyl leukotriene receptor 1 ) | 0.638913 | 0 | 0 | 0 | 0 |
8 | hsa4988 ( opioid receptor mu 1 ) | 0.627241 | 0 | 0 | 0 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.597318 | 0 | 0 | 0 | 0 |
10 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.582259 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa148 ( adrenoceptor alpha 1A ) | 0.773694 | 0 | 0 | 0 | 0 |
2 | hsa3274 ( histamine receptor H2 ) | 0.716675 | 0 | 0 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.663485 | 0 | 0 | 0 | 0 |
4 | hsa147 ( adrenoceptor alpha 1B ) | 0.627452 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.611691 | 0 | 0 | 0 | 0 |
6 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.593178 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.579937 | 0 | 0 | 0 | 0 |
8 | hsa151 ( adrenoceptor alpha 2B ) | 0.574645 | 0 | 0 | 0 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.529097 | 0 | 0 | 0 | 0 |
10 | hsa3362 ( 5-hydroxytryptamine receptor 6 ) | 0.51487 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1814 ( dopamine receptor D3 ) | 0.907228 | 1 | 0 | 1 | 0 |
2 | hsa1812 ( dopamine receptor D1 ) | 0.90315 | 1 | 0 | 1 | 0 |
3 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.873876 | 1 | 0 | 1 | 0 |
4 | hsa3269 ( histamine receptor H1 ) | 0.8435 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.782033 | 1 | 0 | 1 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.756404 | 1 | 0 | 1 | 0 |
7 | hsa1816 ( dopamine receptor D5 ) | 0.748937 | 1 | 0 | 1 | 0 |
8 | hsa148 ( adrenoceptor alpha 1A ) | 0.747962 | 0 | 0 | 0 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.725716 | 0 | 0 | 0 | 0 |
10 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.649338 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.742386 | 1 | 0 | 1 | 0 |
2 | hsa154 ( adrenoceptor beta 2 ) | 0.711142 | 1 | 0 | 1 | 0 |
3 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.681888 | 0 | 0 | 0 | 0 |
4 | hsa155 ( adrenoceptor beta 3 ) | 0.63929 | 1 | 0 | 1 | 0 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.63217 | 0 | 0 | 0 | 0 |
6 | hsa3274 ( histamine receptor H2 ) | 0.576928 | 0 | 0 | 0 | 0 |
7 | hsa3269 ( histamine receptor H1 ) | 0.576783 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.543723 | 0 | 0 | 0 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.522139 | 0 | 0 | 0 | 0 |
10 | hsa185 ( angiotensin II receptor type 1 ) | 0.513244 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa64805 ( purinergic receptor P2Y12 ) | 0.696511 | 0 | 0 | 0 | 0 |
2 | hsa154 ( adrenoceptor beta 2 ) | 0.696317 | 0 | 0 | 0 | 0 |
3 | hsa185 ( angiotensin II receptor type 1 ) | 0.682561 | 0 | 0 | 0 | 0 |
4 | hsa3269 ( histamine receptor H1 ) | 0.676109 | 0 | 0 | 0 | 0 |
5 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.664808 | 0 | 0 | 0 | 0 |
6 | hsa10800 ( cysteinyl leukotriene receptor 1 ) | 0.657322 | 0 | 0 | 0 | 0 |
7 | hsa153 ( adrenoceptor beta 1 ) | 0.648814 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.64087 | 0 | 0 | 0 | 0 |
9 | hsa1813 ( dopamine receptor D2 ) | 0.634154 | 0 | 0 | 0 | 0 |
10 | hsa6915 ( thromboxane A2 receptor ) | 0.603913 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa147 ( adrenoceptor alpha 1B ) | 0.94634 | 1 | 0 | 1 | 0 |
2 | hsa146 ( adrenoceptor alpha 1D ) | 0.941159 | 1 | 0 | 1 | 0 |
3 | hsa150 ( adrenoceptor alpha 2A ) | 0.824826 | 0 | 0 | 0 | 0 |
4 | hsa151 ( adrenoceptor alpha 2B ) | 0.81169 | 0 | 0 | 0 | 0 |
5 | hsa153 ( adrenoceptor beta 1 ) | 0.751631 | 0 | 0 | 0 | 0 |
6 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.734563 | 0 | 0 | 0 | 0 |
7 | hsa152 ( adrenoceptor alpha 2C ) | 0.733915 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.708712 | 0 | 0 | 0 | 0 |
9 | hsa3269 ( histamine receptor H1 ) | 0.674974 | 0 | 0 | 0 | 0 |
10 | hsa3274 ( histamine receptor H2 ) | 0.661772 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.975956 | 1 | 0 | 1 | 0 |
2 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.964707 | 1 | 0 | 1 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.92696 | 0 | 0 | 0 | 0 |
4 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.878398 | 1 | 0 | 1 | 0 |
5 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.846795 | 1 | 0 | 1 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.65681 | 0 | 0 | 0 | 0 |
7 | hsa4988 ( opioid receptor mu 1 ) | 0.612496 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.590117 | 0 | 0 | 0 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.583836 | 0 | 0 | 0 | 0 |
10 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.576109 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa136 ( adenosine A2b receptor ) | 0.964312 | 1 | 0 | 1 | 0 |
2 | hsa140 ( adenosine A3 receptor ) | 0.942932 | 0 | 0 | 0 | 0 |
3 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.838086 | 0 | 0 | 0 | 0 |
4 | hsa64805 ( purinergic receptor P2Y12 ) | 0.77283 | 0 | 0 | 0 | 0 |
5 | hsa185 ( angiotensin II receptor type 1 ) | 0.768623 | 0 | 0 | 0 | 0 |
6 | hsa150 ( adrenoceptor alpha 2A ) | 0.671507 | 0 | 0 | 0 | 0 |
7 | hsa5029 ( purinergic receptor P2Y2 ) | 0.637303 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.635815 | 0 | 0 | 0 | 0 |
9 | hsa10161 ( lysophosphatidic acid receptor 6 ) | 0.614651 | 0 | 0 | 0 | 0 |
10 | hsa5031 ( pyrimidinergic receptor P2Y6 ) | 0.609895 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1813 ( dopamine receptor D2 ) | 0.794496 | 0 | 0 | 0 | 0 |
2 | hsa152 ( adrenoceptor alpha 2C ) | 0.785882 | 0 | 0 | 0 | 0 |
3 | hsa153 ( adrenoceptor beta 1 ) | 0.756924 | 0 | 0 | 0 | 0 |
4 | hsa154 ( adrenoceptor beta 2 ) | 0.740824 | 0 | 0 | 0 | 0 |
5 | hsa1812 ( dopamine receptor D1 ) | 0.700652 | 0 | 0 | 0 | 0 |
6 | hsa59340 ( histamine receptor H4 ) | 0.644274 | 0 | 0 | 0 | 0 |
7 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.635811 | 0 | 0 | 0 | 0 |
8 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.629858 | 0 | 0 | 0 | 0 |
9 | hsa155 ( adrenoceptor beta 3 ) | 0.628854 | 0 | 0 | 0 | 0 |
10 | hsa1814 ( dopamine receptor D3 ) | 0.614838 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.841436 | 0 | 0 | 0 | 0 |
2 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.77355 | 0 | 0 | 0 | 0 |
3 | hsa11255 ( histamine receptor H3 ) | 0.73669 | 0 | 0 | 0 | 0 |
4 | hsa185 ( angiotensin II receptor type 1 ) | 0.690482 | 0 | 0 | 0 | 0 |
5 | hsa59340 ( histamine receptor H4 ) | 0.678874 | 0 | 0 | 0 | 0 |
6 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.669188 | 0 | 0 | 0 | 0 |
7 | hsa1813 ( dopamine receptor D2 ) | 0.604258 | 0 | 0 | 0 | 0 |
8 | hsa4988 ( opioid receptor mu 1 ) | 0.597304 | 0 | 0 | 0 | 0 |
9 | hsa9052 ( G protein-coupled receptor class C group 5 member A ) | 0.583443 | 0 | 0 | 0 | 0 |
10 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.571262 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1814 ( dopamine receptor D3 ) | 0.929944 | 1 | 0 | 1 | 1 |
2 | hsa1812 ( dopamine receptor D1 ) | 0.929407 | 0 | 0 | 0 | 0 |
3 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.88484 | 0 | 0 | 0 | 0 |
4 | hsa3269 ( histamine receptor H1 ) | 0.848052 | 0 | 0 | 0 | 0 |
5 | hsa1816 ( dopamine receptor D5 ) | 0.792522 | 0 | 0 | 0 | 0 |
6 | hsa150 ( adrenoceptor alpha 2A ) | 0.779571 | 0 | 0 | 0 | 0 |
7 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.760754 | 0 | 0 | 0 | 0 |
8 | hsa151 ( adrenoceptor alpha 2B ) | 0.756554 | 0 | 0 | 0 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.73905 | 0 | 0 | 0 | 0 |
10 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.691366 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.893879 | 0 | 0 | 0 | 0 |
2 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.844495 | 0 | 0 | 0 | 0 |
3 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.800663 | 0 | 0 | 0 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.798319 | 0 | 0 | 0 | 0 |
5 | hsa1812 ( dopamine receptor D1 ) | 0.725797 | 0 | 0 | 0 | 0 |
6 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.703788 | 0 | 0 | 0 | 0 |
7 | hsa59340 ( histamine receptor H4 ) | 0.697644 | 0 | 0 | 0 | 0 |
8 | hsa11255 ( histamine receptor H3 ) | 0.681681 | 0 | 0 | 0 | 0 |
9 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.629857 | 0 | 0 | 0 | 0 |
10 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.616082 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa57105 ( cysteinyl leukotriene receptor 2 ) | 0.896291 | 0 | 0 | 0 | 0 |
2 | hsa5729 ( prostaglandin D2 receptor ) | 0.818801 | 0 | 0 | 0 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.759538 | 0 | 0 | 0 | 0 |
4 | hsa1241 ( leukotriene B4 receptor ) | 0.75819 | 0 | 0 | 0 | 0 |
5 | hsa185 ( angiotensin II receptor type 1 ) | 0.734201 | 0 | 0 | 0 | 0 |
6 | hsa56413 ( leukotriene B4 receptor 2 ) | 0.730748 | 0 | 0 | 0 | 0 |
7 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.723604 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.672523 | 0 | 0 | 0 | 0 |
9 | hsa5724 ( platelet activating factor receptor ) | 0.651763 | 0 | 0 | 0 | 0 |
10 | hsa64805 ( purinergic receptor P2Y12 ) | 0.633626 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3269 ( histamine receptor H1 ) | 0.949425 | 0 | 0 | 0 | 0 |
2 | hsa1813 ( dopamine receptor D2 ) | 0.728955 | 0 | 0 | 0 | 0 |
3 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.680848 | 0 | 0 | 0 | 0 |
4 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.620657 | 0 | 0 | 0 | 0 |
5 | hsa1815 ( dopamine receptor D4 ) | 0.604337 | 0 | 0 | 0 | 0 |
6 | hsa148 ( adrenoceptor alpha 1A ) | 0.564975 | 0 | 0 | 0 | 0 |
7 | hsa1812 ( dopamine receptor D1 ) | 0.562339 | 0 | 0 | 0 | 0 |
8 | hsa4988 ( opioid receptor mu 1 ) | 0.554579 | 0 | 0 | 0 | 0 |
9 | hsa11255 ( histamine receptor H3 ) | 0.55048 | 0 | 0 | 0 | 0 |
10 | hsa154 ( adrenoceptor beta 2 ) | 0.533636 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5731 ( prostaglandin E receptor 1 ) | 0.94291 | 0 | 0 | 0 | 0 |
2 | hsa5732 ( prostaglandin E receptor 2 ) | 0.92573 | 1 | 1 | 0 | 0 |
3 | hsa5737 ( prostaglandin F receptor ) | 0.911761 | 0 | 0 | 0 | 0 |
4 | hsa5739 ( prostaglandin I2 (prostacyclin) receptor (IP) ) | 0.82126 | 0 | 0 | 0 | 0 |
5 | hsa6915 ( thromboxane A2 receptor ) | 0.817362 | 0 | 0 | 0 | 0 |
6 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.711085 | 0 | 0 | 0 | 0 |
7 | hsa4988 ( opioid receptor mu 1 ) | 0.705228 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.674848 | 0 | 0 | 0 | 0 |
9 | hsa153 ( adrenoceptor beta 1 ) | 0.669124 | 0 | 0 | 0 | 0 |
10 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.654995 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4988 ( opioid receptor mu 1 ) | 0.729189 | 0 | 0 | 0 | 0 |
2 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.726037 | 0 | 0 | 0 | 0 |
3 | hsa185 ( angiotensin II receptor type 1 ) | 0.703575 | 0 | 0 | 0 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.652322 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.62692 | 0 | 0 | 0 | 0 |
6 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.62676 | 0 | 0 | 0 | 0 |
7 | hsa5733 ( prostaglandin E receptor 3 ) | 0.61388 | 0 | 0 | 0 | 0 |
8 | hsa4986 ( opioid receptor kappa 1 ) | 0.607337 | 0 | 0 | 0 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.601392 | 0 | 0 | 0 | 0 |
10 | hsa154 ( adrenoceptor beta 2 ) | 0.59364 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5731 ( prostaglandin E receptor 1 ) | 0.925216 | 0 | 0 | 0 | 0 |
2 | hsa5733 ( prostaglandin E receptor 3 ) | 0.912959 | 0 | 0 | 0 | 0 |
3 | hsa5739 ( prostaglandin I2 (prostacyclin) receptor (IP) ) | 0.892354 | 0 | 0 | 0 | 0 |
4 | hsa6915 ( thromboxane A2 receptor ) | 0.871793 | 0 | 0 | 0 | 0 |
5 | hsa5732 ( prostaglandin E receptor 2 ) | 0.83524 | 0 | 0 | 0 | 0 |
6 | hsa4988 ( opioid receptor mu 1 ) | 0.697365 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.645031 | 0 | 0 | 0 | 0 |
8 | hsa64805 ( purinergic receptor P2Y12 ) | 0.628297 | 0 | 0 | 0 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.627752 | 0 | 0 | 0 | 0 |
10 | hsa185 ( angiotensin II receptor type 1 ) | 0.62599 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa151 ( adrenoceptor alpha 2B ) | 0.862047 | 0 | 0 | 0 | 0 |
2 | hsa150 ( adrenoceptor alpha 2A ) | 0.852539 | 0 | 0 | 0 | 0 |
3 | hsa153 ( adrenoceptor beta 1 ) | 0.786752 | 0 | 0 | 0 | 0 |
4 | hsa152 ( adrenoceptor alpha 2C ) | 0.767553 | 0 | 0 | 0 | 0 |
5 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.747887 | 0 | 0 | 0 | 0 |
6 | hsa154 ( adrenoceptor beta 2 ) | 0.744915 | 0 | 0 | 0 | 0 |
7 | hsa3269 ( histamine receptor H1 ) | 0.678652 | 0 | 0 | 0 | 0 |
8 | hsa1813 ( dopamine receptor D2 ) | 0.667379 | 0 | 0 | 0 | 0 |
9 | hsa155 ( adrenoceptor beta 3 ) | 0.64825 | 0 | 0 | 0 | 0 |
10 | hsa3274 ( histamine receptor H2 ) | 0.631763 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.950306 | 0 | 0 | 0 | 0 |
2 | hsa3361 ( 5-hydroxytryptamine receptor 5A ) | 0.921592 | 0 | 0 | 0 | 0 |
3 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.908722 | 0 | 0 | 0 | 0 |
4 | hsa1814 ( dopamine receptor D3 ) | 0.872708 | 0 | 0 | 0 | 0 |
5 | hsa148 ( adrenoceptor alpha 1A ) | 0.869653 | 0 | 0 | 0 | 0 |
6 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.86753 | 0 | 0 | 0 | 0 |
7 | hsa1813 ( dopamine receptor D2 ) | 0.829226 | 0 | 0 | 0 | 0 |
8 | hsa147 ( adrenoceptor alpha 1B ) | 0.785285 | 0 | 0 | 0 | 0 |
9 | hsa3362 ( 5-hydroxytryptamine receptor 6 ) | 0.770054 | 0 | 0 | 0 | 0 |
10 | hsa150 ( adrenoceptor alpha 2A ) | 0.763837 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.814877 | 0 | 0 | 0 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.784215 | 0 | 0 | 0 | 0 |
3 | hsa1812 ( dopamine receptor D1 ) | 0.742821 | 0 | 0 | 0 | 0 |
4 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.720065 | 0 | 0 | 0 | 0 |
5 | hsa153 ( adrenoceptor beta 1 ) | 0.700037 | 0 | 0 | 0 | 0 |
6 | hsa4988 ( opioid receptor mu 1 ) | 0.68941 | 0 | 0 | 0 | 0 |
7 | hsa3274 ( histamine receptor H2 ) | 0.680064 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.676481 | 0 | 0 | 0 | 0 |
9 | hsa148 ( adrenoceptor alpha 1A ) | 0.6615 | 0 | 0 | 0 | 0 |
10 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.659844 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4988 ( opioid receptor mu 1 ) | 0.751658 | 0 | 0 | 0 | 0 |
2 | hsa185 ( angiotensin II receptor type 1 ) | 0.710328 | 0 | 0 | 0 | 0 |
3 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.696244 | 0 | 0 | 0 | 0 |
4 | hsa5733 ( prostaglandin E receptor 3 ) | 0.644259 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.633742 | 0 | 0 | 0 | 0 |
6 | hsa4986 ( opioid receptor kappa 1 ) | 0.633082 | 0 | 0 | 0 | 0 |
7 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.621684 | 0 | 0 | 0 | 0 |
8 | hsa1813 ( dopamine receptor D2 ) | 0.617154 | 0 | 0 | 0 | 0 |
9 | hsa5731 ( prostaglandin E receptor 1 ) | 0.597547 | 0 | 0 | 0 | 0 |
10 | hsa154 ( adrenoceptor beta 2 ) | 0.577801 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3274 ( histamine receptor H2 ) | 0.733455 | 0 | 0 | 0 | 0 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.718563 | 0 | 0 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.607263 | 0 | 0 | 0 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.58192 | 0 | 0 | 0 | 0 |
5 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.576388 | 0 | 0 | 0 | 0 |
6 | hsa147 ( adrenoceptor alpha 1B ) | 0.568991 | 0 | 0 | 0 | 0 |
7 | hsa151 ( adrenoceptor alpha 2B ) | 0.548089 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.545975 | 0 | 0 | 0 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.521167 | 1 | 0 | 0 | 1 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.518723 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3269 ( histamine receptor H1 ) | 0.933389 | 0 | 0 | 0 | 0 |
2 | hsa1813 ( dopamine receptor D2 ) | 0.667863 | 0 | 0 | 0 | 0 |
3 | hsa4988 ( opioid receptor mu 1 ) | 0.646198 | 0 | 0 | 0 | 0 |
4 | hsa154 ( adrenoceptor beta 2 ) | 0.573735 | 0 | 0 | 0 | 0 |
5 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.566791 | 0 | 0 | 0 | 0 |
6 | hsa1815 ( dopamine receptor D4 ) | 0.562316 | 0 | 0 | 0 | 0 |
7 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.552719 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.546819 | 0 | 0 | 0 | 0 |
9 | hsa11255 ( histamine receptor H3 ) | 0.544797 | 0 | 0 | 0 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.536043 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa146 ( adrenoceptor alpha 1D ) | 0.858529 | 0 | 0 | 0 | 0 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.845023 | 0 | 0 | 0 | 0 |
3 | hsa147 ( adrenoceptor alpha 1B ) | 0.833143 | 0 | 0 | 0 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.715217 | 0 | 0 | 0 | 0 |
5 | hsa154 ( adrenoceptor beta 2 ) | 0.685475 | 0 | 0 | 0 | 0 |
6 | hsa153 ( adrenoceptor beta 1 ) | 0.670931 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.637707 | 0 | 0 | 0 | 0 |
8 | hsa185 ( angiotensin II receptor type 1 ) | 0.573856 | 0 | 0 | 0 | 0 |
9 | hsa155 ( adrenoceptor beta 3 ) | 0.573055 | 0 | 0 | 0 | 0 |
10 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.549711 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.825985 | 0 | 0 | 0 | 0 |
2 | hsa4988 ( opioid receptor mu 1 ) | 0.780893 | 0 | 0 | 0 | 0 |
3 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.689878 | 0 | 0 | 0 | 0 |
4 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.649725 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.644197 | 0 | 0 | 0 | 0 |
6 | hsa64805 ( purinergic receptor P2Y12 ) | 0.615767 | 0 | 0 | 0 | 0 |
7 | hsa4986 ( opioid receptor kappa 1 ) | 0.604455 | 0 | 0 | 0 | 0 |
8 | hsa10800 ( cysteinyl leukotriene receptor 1 ) | 0.60167 | 0 | 0 | 0 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.600643 | 0 | 0 | 0 | 0 |
10 | hsa148 ( adrenoceptor alpha 1A ) | 0.59473 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.9739 | 1 | 0 | 1 | 1 |
2 | hsa155 ( adrenoceptor beta 3 ) | 0.930916 | 1 | 0 | 0 | 1 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.732368 | 0 | 0 | 0 | 0 |
4 | hsa3274 ( histamine receptor H2 ) | 0.700148 | 0 | 0 | 0 | 0 |
5 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.627626 | 0 | 0 | 0 | 0 |
6 | hsa146 ( adrenoceptor alpha 1D ) | 0.618574 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.613235 | 0 | 0 | 0 | 0 |
8 | hsa147 ( adrenoceptor alpha 1B ) | 0.585138 | 0 | 0 | 0 | 0 |
9 | hsa151 ( adrenoceptor alpha 2B ) | 0.578855 | 0 | 0 | 0 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.57473 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3274 ( histamine receptor H2 ) | 0.630428 | 0 | 0 | 0 | 0 |
2 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.552656 | 0 | 0 | 0 | 0 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.544467 | 0 | 0 | 0 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.507274 | 0 | 0 | 0 | 0 |
5 | hsa1812 ( dopamine receptor D1 ) | 0.477014 | 0 | 0 | 0 | 0 |
6 | hsa185 ( angiotensin II receptor type 1 ) | 0.456921 | 0 | 0 | 0 | 0 |
7 | hsa1816 ( dopamine receptor D5 ) | 0.426558 | 0 | 0 | 0 | 0 |
8 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.418545 | 0 | 0 | 0 | 0 |
9 | hsa3269 ( histamine receptor H1 ) | 0.410696 | 0 | 0 | 0 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.400263 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa148 ( adrenoceptor alpha 1A ) | 0.787053 | 0 | 0 | 0 | 0 |
2 | hsa3274 ( histamine receptor H2 ) | 0.704477 | 0 | 0 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.68202 | 0 | 0 | 0 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.650035 | 0 | 0 | 0 | 0 |
5 | hsa147 ( adrenoceptor alpha 1B ) | 0.646142 | 0 | 0 | 0 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.620736 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.564131 | 0 | 0 | 0 | 0 |
8 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.530495 | 0 | 0 | 0 | 0 |
9 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.525187 | 0 | 0 | 0 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.52243 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa151 ( adrenoceptor alpha 2B ) | 0.857303 | 0 | 0 | 0 | 0 |
2 | hsa150 ( adrenoceptor alpha 2A ) | 0.851097 | 0 | 0 | 0 | 0 |
3 | hsa152 ( adrenoceptor alpha 2C ) | 0.777528 | 0 | 0 | 0 | 0 |
4 | hsa153 ( adrenoceptor beta 1 ) | 0.746139 | 0 | 0 | 0 | 0 |
5 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.702946 | 1 | 0 | 1 | 1 |
6 | hsa154 ( adrenoceptor beta 2 ) | 0.692551 | 0 | 0 | 0 | 0 |
7 | hsa3274 ( histamine receptor H2 ) | 0.659172 | 0 | 0 | 0 | 0 |
8 | hsa1813 ( dopamine receptor D2 ) | 0.655903 | 0 | 0 | 0 | 0 |
9 | hsa185 ( angiotensin II receptor type 1 ) | 0.636089 | 0 | 0 | 0 | 0 |
10 | hsa3269 ( histamine receptor H1 ) | 0.634503 | 1 | 1 | 1 | 1 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.729919 | 0 | 0 | 0 | 0 |
2 | hsa154 ( adrenoceptor beta 2 ) | 0.69388 | 0 | 0 | 0 | 0 |
3 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.662365 | 0 | 0 | 0 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.63676 | 0 | 0 | 0 | 0 |
5 | hsa155 ( adrenoceptor beta 3 ) | 0.625603 | 0 | 0 | 0 | 0 |
6 | hsa3274 ( histamine receptor H2 ) | 0.570686 | 0 | 0 | 0 | 0 |
7 | hsa185 ( angiotensin II receptor type 1 ) | 0.559187 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.557036 | 0 | 0 | 0 | 0 |
9 | hsa3269 ( histamine receptor H1 ) | 0.524388 | 0 | 0 | 0 | 0 |
10 | hsa3363 ( 5-hydroxytryptamine receptor 7 ) | 0.483484 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4988 ( opioid receptor mu 1 ) | 0.964655 | 0 | 0 | 0 | 0 |
2 | hsa6751 ( somatostatin receptor 1 ) | 0.928768 | 1 | 1 | 0 | 0 |
3 | hsa4986 ( opioid receptor kappa 1 ) | 0.894767 | 0 | 0 | 0 | 0 |
4 | hsa4985 ( opioid receptor delta 1 ) | 0.814037 | 0 | 0 | 0 | 0 |
5 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.804112 | 0 | 0 | 0 | 0 |
6 | hsa185 ( angiotensin II receptor type 1 ) | 0.793128 | 0 | 0 | 0 | 0 |
7 | hsa886 ( cholecystokinin A receptor ) | 0.671527 | 0 | 0 | 0 | 0 |
8 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.66111 | 0 | 0 | 0 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.65386 | 0 | 0 | 0 | 0 |
10 | hsa6010 ( rhodopsin ) | 0.646739 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2918 ( glutamate metabotropic receptor 8 ) | 0.759851 | 0 | 0 | 0 | 0 |
2 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.733715 | 0 | 0 | 0 | 0 |
3 | hsa2913 ( glutamate metabotropic receptor 3 ) | 0.681301 | 0 | 0 | 0 | 0 |
4 | hsa2916 ( glutamate metabotropic receptor 6 ) | 0.665279 | 0 | 0 | 0 | 0 |
5 | hsa185 ( angiotensin II receptor type 1 ) | 0.6616 | 0 | 0 | 0 | 0 |
6 | hsa2912 ( glutamate metabotropic receptor 2 ) | 0.66065 | 0 | 0 | 0 | 0 |
7 | hsa3269 ( histamine receptor H1 ) | 0.65325 | 0 | 0 | 0 | 0 |
8 | hsa2550 ( gamma-aminobutyric acid type B receptor subunit 1 ) | 0.65311 | 0 | 0 | 0 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.614498 | 0 | 0 | 0 | 0 |
10 | hsa3274 ( histamine receptor H2 ) | 0.614076 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.740021 | 0 | 0 | 0 | 0 |
2 | hsa2918 ( glutamate metabotropic receptor 8 ) | 0.704838 | 0 | 0 | 0 | 0 |
3 | hsa185 ( angiotensin II receptor type 1 ) | 0.676522 | 0 | 0 | 0 | 0 |
4 | hsa2550 ( gamma-aminobutyric acid type B receptor subunit 1 ) | 0.640382 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.625745 | 0 | 0 | 0 | 0 |
6 | hsa2913 ( glutamate metabotropic receptor 3 ) | 0.624009 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.622578 | 0 | 0 | 0 | 0 |
8 | hsa3274 ( histamine receptor H2 ) | 0.619984 | 0 | 0 | 0 | 0 |
9 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.615264 | 0 | 0 | 0 | 0 |
10 | hsa148 ( adrenoceptor alpha 1A ) | 0.610231 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.943366 | 0 | 0 | 0 | 0 |
2 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.906654 | 0 | 0 | 0 | 0 |
3 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.802559 | 0 | 0 | 0 | 0 |
4 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.767945 | 0 | 0 | 0 | 0 |
5 | hsa11255 ( histamine receptor H3 ) | 0.704589 | 0 | 0 | 0 | 0 |
6 | hsa59340 ( histamine receptor H4 ) | 0.687347 | 0 | 0 | 0 | 0 |
7 | hsa1813 ( dopamine receptor D2 ) | 0.669135 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.613804 | 0 | 0 | 0 | 0 |
9 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.600401 | 0 | 0 | 0 | 0 |
10 | hsa148 ( adrenoceptor alpha 1A ) | 0.580363 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa148 ( adrenoceptor alpha 1A ) | 0.759286 | 0 | 0 | 0 | 0 |
2 | hsa3274 ( histamine receptor H2 ) | 0.713179 | 0 | 0 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.645789 | 0 | 0 | 0 | 0 |
4 | hsa147 ( adrenoceptor alpha 1B ) | 0.610827 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.605964 | 0 | 0 | 0 | 0 |
6 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.605656 | 0 | 0 | 0 | 0 |
7 | hsa151 ( adrenoceptor alpha 2B ) | 0.569769 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.55871 | 0 | 0 | 0 | 0 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.525595 | 0 | 0 | 0 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.515049 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1812 ( dopamine receptor D1 ) | 0.945771 | 1 | 0 | 1 | 0 |
2 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.908768 | 1 | 0 | 1 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.874123 | 1 | 0 | 1 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.826255 | 1 | 0 | 1 | 0 |
5 | hsa1816 ( dopamine receptor D5 ) | 0.819387 | 1 | 0 | 1 | 0 |
6 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.803653 | 1 | 0 | 1 | 0 |
7 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.80078 | 1 | 0 | 1 | 0 |
8 | hsa150 ( adrenoceptor alpha 2A ) | 0.796434 | 1 | 0 | 1 | 0 |
9 | hsa151 ( adrenoceptor alpha 2B ) | 0.791049 | 1 | 0 | 1 | 0 |
10 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.78269 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa155 ( adrenoceptor beta 3 ) | 0.932887 | 0 | 0 | 0 | 0 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.727257 | 0 | 0 | 0 | 0 |
3 | hsa3274 ( histamine receptor H2 ) | 0.685232 | 0 | 0 | 0 | 0 |
4 | hsa146 ( adrenoceptor alpha 1D ) | 0.611584 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.599203 | 0 | 0 | 0 | 0 |
6 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.58224 | 0 | 0 | 0 | 0 |
7 | hsa147 ( adrenoceptor alpha 1B ) | 0.57874 | 0 | 0 | 0 | 0 |
8 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.574863 | 0 | 0 | 0 | 0 |
9 | hsa151 ( adrenoceptor alpha 2B ) | 0.564931 | 0 | 0 | 0 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.525948 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa151 ( adrenoceptor alpha 2B ) | 0.951897 | 1 | 1 | 0 | 0 |
2 | hsa152 ( adrenoceptor alpha 2C ) | 0.944364 | 1 | 1 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.828089 | 1 | 1 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.824983 | 1 | 1 | 1 | 0 |
5 | hsa154 ( adrenoceptor beta 2 ) | 0.812127 | 1 | 1 | 1 | 0 |
6 | hsa153 ( adrenoceptor beta 1 ) | 0.798282 | 1 | 1 | 0 | 0 |
7 | hsa147 ( adrenoceptor alpha 1B ) | 0.795461 | 1 | 1 | 0 | 0 |
8 | hsa155 ( adrenoceptor beta 3 ) | 0.719371 | 1 | 1 | 0 | 0 |
9 | hsa1813 ( dopamine receptor D2 ) | 0.68766 | 0 | 0 | 0 | 0 |
10 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.612812 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1814 ( dopamine receptor D3 ) | 0.872273 | 0 | 0 | 0 | 0 |
2 | hsa1816 ( dopamine receptor D5 ) | 0.699385 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.648341 | 0 | 0 | 0 | 0 |
4 | hsa151 ( adrenoceptor alpha 2B ) | 0.635942 | 0 | 0 | 0 | 0 |
5 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.592561 | 0 | 0 | 0 | 0 |
6 | hsa150 ( adrenoceptor alpha 2A ) | 0.582986 | 0 | 0 | 0 | 0 |
7 | hsa3362 ( 5-hydroxytryptamine receptor 6 ) | 0.538225 | 0 | 0 | 0 | 0 |
8 | hsa146 ( adrenoceptor alpha 1D ) | 0.534262 | 0 | 0 | 0 | 0 |
9 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.533774 | 0 | 0 | 0 | 0 |
10 | hsa147 ( adrenoceptor alpha 1B ) | 0.516742 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa152 ( adrenoceptor alpha 2C ) | 0.878624 | 0 | 0 | 0 | 0 |
2 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.819186 | 0 | 0 | 0 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.790189 | 0 | 0 | 0 | 0 |
4 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.711195 | 0 | 0 | 0 | 0 |
5 | hsa153 ( adrenoceptor beta 1 ) | 0.680684 | 0 | 0 | 0 | 0 |
6 | hsa154 ( adrenoceptor beta 2 ) | 0.660408 | 0 | 0 | 0 | 0 |
7 | hsa1813 ( dopamine receptor D2 ) | 0.658133 | 0 | 0 | 0 | 0 |
8 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.649439 | 0 | 0 | 0 | 0 |
9 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.631314 | 0 | 0 | 0 | 0 |
10 | hsa155 ( adrenoceptor beta 3 ) | 0.582436 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1813 ( dopamine receptor D2 ) | 0.933243 | 0 | 0 | 0 | 0 |
2 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.919894 | 1 | 1 | 1 | 0 |
3 | hsa1814 ( dopamine receptor D3 ) | 0.878487 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.855746 | 0 | 0 | 0 | 0 |
5 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.837427 | 1 | 1 | 1 | 0 |
6 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.806587 | 1 | 0 | 1 | 0 |
7 | hsa1812 ( dopamine receptor D1 ) | 0.801774 | 0 | 0 | 0 | 0 |
8 | hsa146 ( adrenoceptor alpha 1D ) | 0.797784 | 0 | 0 | 0 | 0 |
9 | hsa3269 ( histamine receptor H1 ) | 0.789101 | 0 | 0 | 0 | 0 |
10 | hsa147 ( adrenoceptor alpha 1B ) | 0.785911 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.981689 | 1 | 0 | 1 | 0 |
2 | hsa155 ( adrenoceptor beta 3 ) | 0.937916 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.750818 | 0 | 0 | 0 | 0 |
4 | hsa3274 ( histamine receptor H2 ) | 0.718107 | 0 | 0 | 0 | 0 |
5 | hsa146 ( adrenoceptor alpha 1D ) | 0.627075 | 0 | 0 | 0 | 0 |
6 | hsa147 ( adrenoceptor alpha 1B ) | 0.598757 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.581798 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.575053 | 0 | 0 | 0 | 0 |
9 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.559276 | 0 | 0 | 0 | 0 |
10 | hsa151 ( adrenoceptor alpha 2B ) | 0.549758 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.970261 | 0 | 0 | 0 | 0 |
2 | hsa155 ( adrenoceptor beta 3 ) | 0.920885 | 0 | 0 | 0 | 0 |
3 | hsa3274 ( histamine receptor H2 ) | 0.685747 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.662619 | 0 | 0 | 0 | 0 |
5 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.620361 | 0 | 0 | 0 | 0 |
6 | hsa150 ( adrenoceptor alpha 2A ) | 0.57304 | 0 | 0 | 0 | 0 |
7 | hsa1812 ( dopamine receptor D1 ) | 0.572505 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.560738 | 0 | 0 | 0 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.55635 | 0 | 0 | 0 | 0 |
10 | hsa146 ( adrenoceptor alpha 1D ) | 0.538105 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa151 ( adrenoceptor alpha 2B ) | 0.773361 | 0 | 0 | 0 | 0 |
2 | hsa1814 ( dopamine receptor D3 ) | 0.731869 | 0 | 0 | 0 | 0 |
3 | hsa150 ( adrenoceptor alpha 2A ) | 0.689428 | 0 | 0 | 0 | 0 |
4 | hsa154 ( adrenoceptor beta 2 ) | 0.613825 | 0 | 0 | 0 | 0 |
5 | hsa153 ( adrenoceptor beta 1 ) | 0.601956 | 0 | 0 | 0 | 0 |
6 | hsa1816 ( dopamine receptor D5 ) | 0.56621 | 0 | 0 | 0 | 0 |
7 | hsa59340 ( histamine receptor H4 ) | 0.546844 | 0 | 0 | 0 | 0 |
8 | hsa3362 ( 5-hydroxytryptamine receptor 6 ) | 0.513102 | 0 | 0 | 0 | 0 |
9 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.481044 | 0 | 0 | 0 | 0 |
10 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.4674 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa148 ( adrenoceptor alpha 1A ) | 0.763458 | 0 | 0 | 0 | 0 |
2 | hsa3274 ( histamine receptor H2 ) | 0.69745 | 0 | 0 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.65426 | 0 | 0 | 0 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.634192 | 0 | 0 | 0 | 0 |
5 | hsa147 ( adrenoceptor alpha 1B ) | 0.6176 | 0 | 0 | 0 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.591046 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.568265 | 0 | 0 | 0 | 0 |
8 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.565501 | 0 | 0 | 0 | 0 |
9 | hsa136 ( adenosine A2b receptor ) | 0.506974 | 0 | 0 | 0 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.503372 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa147 ( adrenoceptor alpha 1B ) | 0.813609 | 1 | 0 | 1 | 0 |
2 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.801997 | 1 | 0 | 1 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.796095 | 1 | 0 | 1 | 0 |
4 | hsa3274 ( histamine receptor H2 ) | 0.735389 | 0 | 0 | 0 | 0 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.712478 | 1 | 0 | 1 | 0 |
6 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.686396 | 1 | 0 | 1 | 0 |
7 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.671586 | 1 | 0 | 1 | 0 |
8 | hsa151 ( adrenoceptor alpha 2B ) | 0.630444 | 1 | 0 | 1 | 0 |
9 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.627028 | 1 | 0 | 1 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.62194 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.896157 | 0 | 0 | 0 | 0 |
2 | hsa154 ( adrenoceptor beta 2 ) | 0.725553 | 0 | 0 | 0 | 0 |
3 | hsa1814 ( dopamine receptor D3 ) | 0.722956 | 0 | 0 | 0 | 0 |
4 | hsa3352 ( 5-hydroxytryptamine receptor 1D ) | 0.722232 | 0 | 0 | 0 | 0 |
5 | hsa3351 ( 5-hydroxytryptamine receptor 1B ) | 0.717489 | 0 | 0 | 0 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.715737 | 0 | 0 | 0 | 0 |
7 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.712875 | 0 | 0 | 0 | 0 |
8 | hsa150 ( adrenoceptor alpha 2A ) | 0.700599 | 0 | 0 | 0 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.676995 | 0 | 0 | 0 | 0 |
10 | hsa153 ( adrenoceptor beta 1 ) | 0.665766 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4988 ( opioid receptor mu 1 ) | 0.750702 | 0 | 0 | 0 | 0 |
2 | hsa185 ( angiotensin II receptor type 1 ) | 0.701356 | 0 | 0 | 0 | 0 |
3 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.679949 | 0 | 0 | 0 | 0 |
4 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.674602 | 0 | 0 | 0 | 0 |
5 | hsa4986 ( opioid receptor kappa 1 ) | 0.625657 | 0 | 0 | 0 | 0 |
6 | hsa5733 ( prostaglandin E receptor 3 ) | 0.613691 | 0 | 0 | 0 | 0 |
7 | hsa1813 ( dopamine receptor D2 ) | 0.610607 | 0 | 0 | 0 | 0 |
8 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.603571 | 0 | 0 | 0 | 0 |
9 | hsa3269 ( histamine receptor H1 ) | 0.602773 | 0 | 0 | 0 | 0 |
10 | hsa150 ( adrenoceptor alpha 2A ) | 0.587358 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.982608 | 0 | 0 | 0 | 0 |
2 | hsa155 ( adrenoceptor beta 3 ) | 0.939121 | 0 | 0 | 0 | 0 |
3 | hsa3274 ( histamine receptor H2 ) | 0.72076 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.716875 | 0 | 0 | 0 | 0 |
5 | hsa146 ( adrenoceptor alpha 1D ) | 0.584754 | 0 | 0 | 0 | 0 |
6 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.57147 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.571423 | 0 | 0 | 0 | 0 |
8 | hsa1812 ( dopamine receptor D1 ) | 0.560997 | 0 | 0 | 0 | 0 |
9 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.552192 | 0 | 0 | 0 | 0 |
10 | hsa147 ( adrenoceptor alpha 1B ) | 0.549851 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3269 ( histamine receptor H1 ) | 0.918246 | 0 | 0 | 0 | 0 |
2 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.796978 | 0 | 0 | 0 | 0 |
3 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.761456 | 0 | 0 | 0 | 0 |
4 | hsa151 ( adrenoceptor alpha 2B ) | 0.72957 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.722497 | 0 | 0 | 0 | 0 |
6 | hsa148 ( adrenoceptor alpha 1A ) | 0.718824 | 0 | 0 | 0 | 0 |
7 | hsa1815 ( dopamine receptor D4 ) | 0.695621 | 0 | 0 | 0 | 0 |
8 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.684245 | 0 | 0 | 0 | 0 |
9 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.651497 | 0 | 0 | 0 | 0 |
10 | hsa154 ( adrenoceptor beta 2 ) | 0.64123 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5737 ( prostaglandin F receptor ) | 0.931409 | 0 | 0 | 0 | 0 |
2 | hsa5732 ( prostaglandin E receptor 2 ) | 0.920371 | 0 | 0 | 0 | 0 |
3 | hsa5733 ( prostaglandin E receptor 3 ) | 0.900744 | 0 | 0 | 0 | 0 |
4 | hsa6915 ( thromboxane A2 receptor ) | 0.8107 | 0 | 0 | 0 | 0 |
5 | hsa4988 ( opioid receptor mu 1 ) | 0.725057 | 0 | 0 | 0 | 0 |
6 | hsa64805 ( purinergic receptor P2Y12 ) | 0.701652 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.660557 | 0 | 0 | 0 | 0 |
8 | hsa153 ( adrenoceptor beta 1 ) | 0.657774 | 0 | 0 | 0 | 0 |
9 | hsa5729 ( prostaglandin D2 receptor ) | 0.622092 | 0 | 0 | 0 | 0 |
10 | hsa3269 ( histamine receptor H1 ) | 0.61195 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5732 ( prostaglandin E receptor 2 ) | 0.936971 | 1 | 1 | 0 | 0 |
2 | hsa5737 ( prostaglandin F receptor ) | 0.926372 | 0 | 0 | 0 | 0 |
3 | hsa5739 ( prostaglandin I2 (prostacyclin) receptor (IP) ) | 0.893277 | 0 | 0 | 0 | 0 |
4 | hsa6915 ( thromboxane A2 receptor ) | 0.841594 | 0 | 0 | 0 | 0 |
5 | hsa4988 ( opioid receptor mu 1 ) | 0.731669 | 0 | 0 | 0 | 0 |
6 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.684749 | 0 | 0 | 0 | 0 |
7 | hsa153 ( adrenoceptor beta 1 ) | 0.637511 | 0 | 0 | 0 | 0 |
8 | hsa154 ( adrenoceptor beta 2 ) | 0.63015 | 0 | 0 | 0 | 0 |
9 | hsa10800 ( cysteinyl leukotriene receptor 1 ) | 0.601986 | 0 | 0 | 0 | 0 |
10 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.59977 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.94809 | 0 | 0 | 0 | 0 |
2 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.885639 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.854684 | 0 | 0 | 0 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.845101 | 0 | 0 | 0 | 0 |
5 | hsa3354 ( 5-hydroxytryptamine receptor 1E ) | 0.839472 | 0 | 0 | 0 | 0 |
6 | hsa1814 ( dopamine receptor D3 ) | 0.83433 | 0 | 0 | 0 | 0 |
7 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.819549 | 0 | 0 | 0 | 0 |
8 | hsa3361 ( 5-hydroxytryptamine receptor 5A ) | 0.811234 | 0 | 0 | 0 | 0 |
9 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.800624 | 0 | 0 | 0 | 0 |
10 | hsa150 ( adrenoceptor alpha 2A ) | 0.799518 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa136 ( adenosine A2b receptor ) | 0.959827 | 0 | 0 | 0 | 0 |
2 | hsa140 ( adenosine A3 receptor ) | 0.939955 | 0 | 0 | 0 | 0 |
3 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.832699 | 0 | 0 | 0 | 0 |
4 | hsa185 ( angiotensin II receptor type 1 ) | 0.769503 | 0 | 0 | 0 | 0 |
5 | hsa64805 ( purinergic receptor P2Y12 ) | 0.751477 | 0 | 0 | 0 | 0 |
6 | hsa150 ( adrenoceptor alpha 2A ) | 0.675221 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.639887 | 0 | 0 | 0 | 0 |
8 | hsa5029 ( purinergic receptor P2Y2 ) | 0.628208 | 0 | 0 | 0 | 0 |
9 | hsa10161 ( lysophosphatidic acid receptor 6 ) | 0.608439 | 0 | 0 | 0 | 0 |
10 | hsa5731 ( prostaglandin E receptor 1 ) | 0.606928 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.94206 | 0 | 0 | 0 | 0 |
2 | hsa147 ( adrenoceptor alpha 1B ) | 0.912605 | 1 | 1 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.9125 | 1 | 1 | 0 | 0 |
4 | hsa155 ( adrenoceptor beta 3 ) | 0.881678 | 0 | 0 | 0 | 0 |
5 | hsa3274 ( histamine receptor H2 ) | 0.732313 | 0 | 0 | 0 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.715043 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.699338 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.619956 | 0 | 0 | 0 | 0 |
9 | hsa1813 ( dopamine receptor D2 ) | 0.590885 | 0 | 0 | 0 | 0 |
10 | hsa3269 ( histamine receptor H1 ) | 0.589997 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1814 ( dopamine receptor D3 ) | 0.925562 | 1 | 0 | 1 | 0 |
2 | hsa1812 ( dopamine receptor D1 ) | 0.911101 | 1 | 0 | 1 | 0 |
3 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.867659 | 1 | 0 | 1 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.793849 | 1 | 0 | 1 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.767265 | 0 | 0 | 0 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.760281 | 1 | 0 | 1 | 0 |
7 | hsa1816 ( dopamine receptor D5 ) | 0.757166 | 1 | 0 | 1 | 0 |
8 | hsa148 ( adrenoceptor alpha 1A ) | 0.737631 | 1 | 0 | 1 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.672281 | 0 | 0 | 0 | 0 |
10 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.648392 | 1 | 0 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5731 ( prostaglandin E receptor 1 ) | 0.950326 | 0 | 0 | 0 | 0 |
2 | hsa5733 ( prostaglandin E receptor 3 ) | 0.950291 | 0 | 0 | 0 | 0 |
3 | hsa5739 ( prostaglandin I2 (prostacyclin) receptor (IP) ) | 0.927026 | 0 | 0 | 0 | 0 |
4 | hsa5737 ( prostaglandin F receptor ) | 0.900622 | 0 | 0 | 0 | 0 |
5 | hsa6915 ( thromboxane A2 receptor ) | 0.792534 | 0 | 0 | 0 | 0 |
6 | hsa4988 ( opioid receptor mu 1 ) | 0.693355 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.671155 | 0 | 0 | 0 | 0 |
8 | hsa153 ( adrenoceptor beta 1 ) | 0.666206 | 0 | 0 | 0 | 0 |
9 | hsa5729 ( prostaglandin D2 receptor ) | 0.65579 | 0 | 0 | 0 | 0 |
10 | hsa185 ( angiotensin II receptor type 1 ) | 0.636771 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa185 ( angiotensin II receptor type 1 ) | 0.875741 | 0 | 0 | 0 | 0 |
2 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.851047 | 0 | 0 | 0 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.741269 | 0 | 0 | 0 | 0 |
4 | hsa4988 ( opioid receptor mu 1 ) | 0.692334 | 0 | 0 | 0 | 0 |
5 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.689399 | 0 | 0 | 0 | 0 |
6 | hsa148 ( adrenoceptor alpha 1A ) | 0.683348 | 0 | 0 | 0 | 0 |
7 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.655914 | 0 | 0 | 0 | 0 |
8 | hsa3352 ( 5-hydroxytryptamine receptor 1D ) | 0.606184 | 0 | 0 | 0 | 0 |
9 | hsa3351 ( 5-hydroxytryptamine receptor 1B ) | 0.605481 | 0 | 0 | 0 | 0 |
10 | hsa147 ( adrenoceptor alpha 1B ) | 0.596515 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa146 ( adrenoceptor alpha 1D ) | 0.818984 | 1 | 0 | 1 | 0 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.801961 | 1 | 0 | 1 | 0 |
3 | hsa147 ( adrenoceptor alpha 1B ) | 0.784648 | 1 | 0 | 1 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.767854 | 1 | 1 | 1 | 1 |
5 | hsa154 ( adrenoceptor beta 2 ) | 0.672819 | 0 | 0 | 0 | 0 |
6 | hsa153 ( adrenoceptor beta 1 ) | 0.647123 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.630337 | 0 | 0 | 0 | 0 |
8 | hsa1814 ( dopamine receptor D3 ) | 0.611737 | 1 | 0 | 1 | 1 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.610997 | 1 | 0 | 1 | 1 |
10 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.587254 | 1 | 1 | 1 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa338442 ( hydroxycarboxylic acid receptor 2 ) | 0.845737 | 0 | 0 | 0 | 0 |
2 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.773361 | 0 | 0 | 0 | 0 |
3 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.735444 | 0 | 0 | 0 | 0 |
4 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.728647 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.723563 | 0 | 0 | 0 | 0 |
6 | hsa185 ( angiotensin II receptor type 1 ) | 0.723077 | 0 | 0 | 0 | 0 |
7 | hsa4988 ( opioid receptor mu 1 ) | 0.702348 | 0 | 0 | 0 | 0 |
8 | hsa1813 ( dopamine receptor D2 ) | 0.637047 | 0 | 0 | 0 | 0 |
9 | hsa10800 ( cysteinyl leukotriene receptor 1 ) | 0.596849 | 0 | 0 | 0 | 0 |
10 | hsa9283 ( G protein-coupled receptor 37 like 1 ) | 0.562615 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa148 ( adrenoceptor alpha 1A ) | 0.763192 | 1 | 1 | 1 | 1 |
2 | hsa3274 ( histamine receptor H2 ) | 0.696853 | 0 | 0 | 0 | 0 |
3 | hsa150 ( adrenoceptor alpha 2A ) | 0.689605 | 1 | 0 | 1 | 1 |
4 | hsa146 ( adrenoceptor alpha 1D ) | 0.666013 | 1 | 1 | 1 | 1 |
5 | hsa151 ( adrenoceptor alpha 2B ) | 0.652312 | 1 | 0 | 1 | 1 |
6 | hsa147 ( adrenoceptor alpha 1B ) | 0.628422 | 1 | 1 | 1 | 1 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.568281 | 0 | 0 | 0 | 0 |
8 | hsa152 ( adrenoceptor alpha 2C ) | 0.554412 | 1 | 0 | 1 | 0 |
9 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.545372 | 0 | 0 | 0 | 0 |
10 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.504304 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.836399 | 0 | 0 | 0 | 0 |
2 | hsa153 ( adrenoceptor beta 1 ) | 0.790497 | 0 | 0 | 0 | 0 |
3 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.689425 | 0 | 0 | 0 | 0 |
4 | hsa155 ( adrenoceptor beta 3 ) | 0.65795 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.652152 | 0 | 0 | 0 | 0 |
6 | hsa5737 ( prostaglandin F receptor ) | 0.634964 | 0 | 0 | 0 | 0 |
7 | hsa6752 ( somatostatin receptor 2 ) | 0.622034 | 0 | 0 | 0 | 0 |
8 | hsa4988 ( opioid receptor mu 1 ) | 0.619553 | 0 | 0 | 0 | 0 |
9 | hsa9052 ( G protein-coupled receptor class C group 5 member A ) | 0.614958 | 0 | 0 | 0 | 0 |
10 | hsa6010 ( rhodopsin ) | 0.614377 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa155 ( adrenoceptor beta 3 ) | 0.934922 | 1 | 1 | 0 | 0 |
2 | hsa3274 ( histamine receptor H2 ) | 0.710338 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.709861 | 0 | 0 | 0 | 0 |
4 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.58727 | 0 | 0 | 0 | 0 |
5 | hsa146 ( adrenoceptor alpha 1D ) | 0.574989 | 0 | 0 | 0 | 0 |
6 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.564547 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.55538 | 0 | 0 | 0 | 0 |
8 | hsa147 ( adrenoceptor alpha 1B ) | 0.544799 | 0 | 0 | 0 | 0 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.531148 | 0 | 0 | 0 | 0 |
10 | hsa151 ( adrenoceptor alpha 2B ) | 0.521661 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.86785 | 0 | 0 | 0 | 0 |
2 | hsa153 ( adrenoceptor beta 1 ) | 0.846216 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.749064 | 0 | 0 | 0 | 0 |
4 | hsa155 ( adrenoceptor beta 3 ) | 0.716895 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.692546 | 0 | 0 | 0 | 0 |
6 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.681507 | 0 | 0 | 0 | 0 |
7 | hsa59340 ( histamine receptor H4 ) | 0.660538 | 0 | 0 | 0 | 0 |
8 | hsa136 ( adenosine A2b receptor ) | 0.646813 | 0 | 0 | 0 | 0 |
9 | hsa147 ( adrenoceptor alpha 1B ) | 0.620211 | 0 | 0 | 0 | 0 |
10 | hsa146 ( adrenoceptor alpha 1D ) | 0.612508 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.86605 | 0 | 0 | 0 | 0 |
2 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.834027 | 0 | 0 | 0 | 0 |
3 | hsa1813 ( dopamine receptor D2 ) | 0.731659 | 0 | 0 | 0 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.700796 | 0 | 0 | 0 | 0 |
5 | hsa148 ( adrenoceptor alpha 1A ) | 0.650022 | 0 | 0 | 0 | 0 |
6 | hsa11255 ( histamine receptor H3 ) | 0.621052 | 0 | 0 | 0 | 0 |
7 | hsa59340 ( histamine receptor H4 ) | 0.602347 | 0 | 0 | 0 | 0 |
8 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.598705 | 0 | 0 | 0 | 0 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.590573 | 0 | 0 | 0 | 0 |
10 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.571216 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5737 ( prostaglandin F receptor ) | 0.822663 | 0 | 0 | 0 | 0 |
2 | hsa5731 ( prostaglandin E receptor 1 ) | 0.793423 | 0 | 0 | 0 | 0 |
3 | hsa5733 ( prostaglandin E receptor 3 ) | 0.772712 | 0 | 0 | 0 | 0 |
4 | hsa154 ( adrenoceptor beta 2 ) | 0.708607 | 0 | 0 | 0 | 0 |
5 | hsa5739 ( prostaglandin I2 (prostacyclin) receptor (IP) ) | 0.69918 | 0 | 0 | 0 | 0 |
6 | hsa5732 ( prostaglandin E receptor 2 ) | 0.67335 | 0 | 0 | 0 | 0 |
7 | hsa4988 ( opioid receptor mu 1 ) | 0.66804 | 0 | 0 | 0 | 0 |
8 | hsa1813 ( dopamine receptor D2 ) | 0.666145 | 0 | 0 | 0 | 0 |
9 | hsa2550 ( gamma-aminobutyric acid type B receptor subunit 1 ) | 0.649275 | 0 | 0 | 0 | 0 |
10 | hsa153 ( adrenoceptor beta 1 ) | 0.646758 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.975593 | 1 | 0 | 1 | 0 |
2 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.965872 | 1 | 0 | 1 | 0 |
3 | hsa3269 ( histamine receptor H1 ) | 0.905022 | 0 | 0 | 0 | 0 |
4 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.878812 | 1 | 0 | 1 | 0 |
5 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.845776 | 1 | 0 | 1 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.670198 | 0 | 0 | 0 | 0 |
7 | hsa148 ( adrenoceptor alpha 1A ) | 0.635138 | 0 | 0 | 0 | 0 |
8 | hsa4988 ( opioid receptor mu 1 ) | 0.620033 | 0 | 0 | 0 | 0 |
9 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.614274 | 0 | 0 | 0 | 0 |
10 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.606449 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3269 ( histamine receptor H1 ) | 0.937523 | 0 | 0 | 0 | 0 |
2 | hsa1132 ( cholinergic receptor muscarinic 4 ) | 0.879692 | 0 | 0 | 0 | 0 |
3 | hsa1133 ( cholinergic receptor muscarinic 5 ) | 0.842781 | 0 | 0 | 0 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.703548 | 0 | 0 | 0 | 0 |
5 | hsa148 ( adrenoceptor alpha 1A ) | 0.646165 | 0 | 0 | 0 | 0 |
6 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.625439 | 0 | 0 | 0 | 0 |
7 | hsa147 ( adrenoceptor alpha 1B ) | 0.559755 | 0 | 0 | 0 | 0 |
8 | hsa146 ( adrenoceptor alpha 1D ) | 0.55474 | 0 | 0 | 0 | 0 |
9 | hsa154 ( adrenoceptor beta 2 ) | 0.554481 | 0 | 0 | 0 | 0 |
10 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.551734 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa148 ( adrenoceptor alpha 1A ) | 0.742638 | 0 | 0 | 0 | 0 |
2 | hsa3274 ( histamine receptor H2 ) | 0.694476 | 0 | 0 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.62771 | 0 | 0 | 0 | 0 |
4 | hsa150 ( adrenoceptor alpha 2A ) | 0.606424 | 0 | 0 | 0 | 0 |
5 | hsa147 ( adrenoceptor alpha 1B ) | 0.588919 | 0 | 0 | 0 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.578542 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.562734 | 0 | 0 | 0 | 0 |
8 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.561716 | 0 | 0 | 0 | 0 |
9 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.543221 | 0 | 0 | 0 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.532808 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa155 ( adrenoceptor beta 3 ) | 0.929561 | 1 | 0 | 0 | 1 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.733692 | 0 | 0 | 0 | 0 |
3 | hsa3274 ( histamine receptor H2 ) | 0.714651 | 0 | 0 | 0 | 0 |
4 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.612258 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.609954 | 0 | 0 | 0 | 0 |
6 | hsa146 ( adrenoceptor alpha 1D ) | 0.609026 | 0 | 0 | 0 | 0 |
7 | hsa147 ( adrenoceptor alpha 1B ) | 0.575846 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.574625 | 0 | 0 | 0 | 0 |
9 | hsa151 ( adrenoceptor alpha 2B ) | 0.573431 | 0 | 0 | 0 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.54843 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa155 ( adrenoceptor beta 3 ) | 0.933283 | 1 | 0 | 0 | 1 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.741157 | 0 | 0 | 0 | 0 |
3 | hsa3274 ( histamine receptor H2 ) | 0.681865 | 0 | 0 | 0 | 0 |
4 | hsa146 ( adrenoceptor alpha 1D ) | 0.627274 | 0 | 0 | 0 | 0 |
5 | hsa150 ( adrenoceptor alpha 2A ) | 0.625571 | 0 | 0 | 0 | 0 |
6 | hsa151 ( adrenoceptor alpha 2B ) | 0.594452 | 0 | 0 | 0 | 0 |
7 | hsa147 ( adrenoceptor alpha 1B ) | 0.592551 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.583993 | 0 | 0 | 0 | 0 |
9 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.554659 | 0 | 0 | 0 | 0 |
10 | hsa1812 ( dopamine receptor D1 ) | 0.536772 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa2914 ( glutamate metabotropic receptor 4 ) | 0.906407 | 0 | 0 | 0 | 0 |
2 | hsa2917 ( glutamate metabotropic receptor 7 ) | 0.901873 | 0 | 0 | 0 | 0 |
3 | hsa222545 ( G protein-coupled receptor class C group 6 member A ) | 0.869369 | 0 | 0 | 0 | 0 |
4 | hsa2911 ( glutamate metabotropic receptor 1 ) | 0.837476 | 0 | 0 | 0 | 0 |
5 | hsa2915 ( glutamate metabotropic receptor 5 ) | 0.825026 | 0 | 0 | 0 | 0 |
6 | hsa3269 ( histamine receptor H1 ) | 0.811971 | 0 | 0 | 0 | 0 |
7 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.725643 | 0 | 0 | 0 | 0 |
8 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.669027 | 0 | 0 | 0 | 0 |
9 | hsa2550 ( gamma-aminobutyric acid type B receptor subunit 1 ) | 0.658964 | 0 | 0 | 0 | 0 |
10 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.623787 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa135 ( adenosine A2a receptor ) | 0.931734 | 1 | 1 | 1 | 0 |
2 | hsa134 ( adenosine A1 receptor ) | 0.930552 | 1 | 1 | 1 | 0 |
3 | hsa140 ( adenosine A3 receptor ) | 0.858908 | 1 | 0 | 1 | 0 |
4 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.81658 | 0 | 0 | 0 | 0 |
5 | hsa185 ( angiotensin II receptor type 1 ) | 0.797035 | 0 | 0 | 0 | 0 |
6 | hsa64805 ( purinergic receptor P2Y12 ) | 0.749921 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.70131 | 0 | 0 | 0 | 0 |
8 | hsa153 ( adrenoceptor beta 1 ) | 0.674738 | 0 | 0 | 0 | 0 |
9 | hsa3274 ( histamine receptor H2 ) | 0.653523 | 0 | 0 | 0 | 0 |
10 | hsa1268 ( cannabinoid receptor 1 ) | 0.643644 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa146 ( adrenoceptor alpha 1D ) | 0.860738 | 1 | 0 | 1 | 0 |
2 | hsa148 ( adrenoceptor alpha 1A ) | 0.850697 | 1 | 0 | 1 | 0 |
3 | hsa147 ( adrenoceptor alpha 1B ) | 0.834603 | 1 | 0 | 1 | 0 |
4 | hsa1813 ( dopamine receptor D2 ) | 0.749953 | 1 | 1 | 1 | 1 |
5 | hsa154 ( adrenoceptor beta 2 ) | 0.691571 | 0 | 0 | 0 | 0 |
6 | hsa153 ( adrenoceptor beta 1 ) | 0.674734 | 0 | 0 | 0 | 0 |
7 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.613874 | 0 | 0 | 0 | 0 |
8 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.594695 | 1 | 1 | 1 | 0 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.585565 | 1 | 0 | 1 | 1 |
10 | hsa155 ( adrenoceptor beta 3 ) | 0.574693 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.83848 | 0 | 0 | 0 | 0 |
2 | hsa4988 ( opioid receptor mu 1 ) | 0.803632 | 0 | 0 | 0 | 0 |
3 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.682725 | 0 | 0 | 0 | 0 |
4 | hsa3269 ( histamine receptor H1 ) | 0.642584 | 0 | 0 | 0 | 0 |
5 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.641418 | 0 | 0 | 0 | 0 |
6 | hsa4986 ( opioid receptor kappa 1 ) | 0.622777 | 0 | 0 | 0 | 0 |
7 | hsa148 ( adrenoceptor alpha 1A ) | 0.614948 | 0 | 0 | 0 | 0 |
8 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.610781 | 0 | 0 | 0 | 0 |
9 | hsa64805 ( purinergic receptor P2Y12 ) | 0.604229 | 0 | 0 | 0 | 0 |
10 | hsa10800 ( cysteinyl leukotriene receptor 1 ) | 0.583885 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa151 ( adrenoceptor alpha 2B ) | 0.964606 | 1 | 1 | 1 | 0 |
2 | hsa152 ( adrenoceptor alpha 2C ) | 0.961343 | 1 | 1 | 0 | 0 |
3 | hsa146 ( adrenoceptor alpha 1D ) | 0.864905 | 0 | 0 | 0 | 0 |
4 | hsa148 ( adrenoceptor alpha 1A ) | 0.854216 | 0 | 0 | 0 | 0 |
5 | hsa147 ( adrenoceptor alpha 1B ) | 0.841165 | 0 | 0 | 0 | 0 |
6 | hsa1813 ( dopamine receptor D2 ) | 0.711185 | 0 | 0 | 0 | 0 |
7 | hsa154 ( adrenoceptor beta 2 ) | 0.673295 | 0 | 0 | 0 | 0 |
8 | hsa153 ( adrenoceptor beta 1 ) | 0.666995 | 0 | 0 | 0 | 0 |
9 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.632719 | 0 | 0 | 0 | 0 |
10 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.622138 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.980864 | 1 | 1 | 1 | 0 |
2 | hsa155 ( adrenoceptor beta 3 ) | 0.941091 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.791035 | 0 | 0 | 0 | 0 |
4 | hsa3274 ( histamine receptor H2 ) | 0.71549 | 0 | 0 | 0 | 0 |
5 | hsa146 ( adrenoceptor alpha 1D ) | 0.677451 | 0 | 0 | 0 | 0 |
6 | hsa147 ( adrenoceptor alpha 1B ) | 0.646003 | 0 | 0 | 0 | 0 |
7 | hsa150 ( adrenoceptor alpha 2A ) | 0.639622 | 0 | 0 | 0 | 0 |
8 | hsa151 ( adrenoceptor alpha 2B ) | 0.607661 | 0 | 0 | 0 | 0 |
9 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.586482 | 0 | 0 | 0 | 0 |
10 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.518974 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4986 ( opioid receptor kappa 1 ) | 0.910516 | 0 | 0 | 0 | 0 |
2 | hsa4985 ( opioid receptor delta 1 ) | 0.815584 | 0 | 0 | 0 | 0 |
3 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.791719 | 0 | 0 | 0 | 0 |
4 | hsa185 ( angiotensin II receptor type 1 ) | 0.770424 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.751819 | 0 | 0 | 0 | 0 |
6 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.740782 | 0 | 0 | 0 | 0 |
7 | hsa6752 ( somatostatin receptor 2 ) | 0.693424 | 0 | 0 | 0 | 0 |
8 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.685914 | 0 | 0 | 0 | 0 |
9 | hsa6755 ( somatostatin receptor 5 ) | 0.641795 | 0 | 0 | 0 | 0 |
10 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.641789 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.85285 | 0 | 0 | 0 | 0 |
2 | hsa1813 ( dopamine receptor D2 ) | 0.790813 | 0 | 0 | 0 | 0 |
3 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.787147 | 0 | 0 | 0 | 0 |
4 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.765895 | 0 | 0 | 0 | 0 |
5 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.72095 | 0 | 0 | 0 | 0 |
6 | hsa148 ( adrenoceptor alpha 1A ) | 0.71755 | 0 | 0 | 0 | 0 |
7 | hsa59340 ( histamine receptor H4 ) | 0.709887 | 0 | 0 | 0 | 0 |
8 | hsa1812 ( dopamine receptor D1 ) | 0.707359 | 0 | 0 | 0 | 0 |
9 | hsa11255 ( histamine receptor H3 ) | 0.671436 | 0 | 0 | 0 | 0 |
10 | hsa147 ( adrenoceptor alpha 1B ) | 0.594776 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4986 ( opioid receptor kappa 1 ) | 0.945851 | 1 | 1 | 1 | 0 |
2 | hsa4985 ( opioid receptor delta 1 ) | 0.882308 | 1 | 1 | 1 | 0 |
3 | hsa185 ( angiotensin II receptor type 1 ) | 0.80546 | 0 | 0 | 0 | 0 |
4 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.723918 | 0 | 0 | 0 | 0 |
5 | hsa6752 ( somatostatin receptor 2 ) | 0.696098 | 0 | 0 | 0 | 0 |
6 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.683649 | 0 | 0 | 0 | 0 |
7 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.664816 | 0 | 0 | 0 | 0 |
8 | hsa6755 ( somatostatin receptor 5 ) | 0.663633 | 0 | 0 | 0 | 0 |
9 | hsa1812 ( dopamine receptor D1 ) | 0.653706 | 0 | 0 | 0 | 0 |
10 | hsa1813 ( dopamine receptor D2 ) | 0.648841 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.762685 | 0 | 0 | 0 | 0 |
2 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.757435 | 0 | 0 | 0 | 0 |
3 | hsa56413 ( leukotriene B4 receptor 2 ) | 0.731982 | 0 | 0 | 0 | 0 |
4 | hsa1241 ( leukotriene B4 receptor ) | 0.729209 | 0 | 0 | 0 | 0 |
5 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.700338 | 0 | 0 | 0 | 0 |
6 | hsa185 ( angiotensin II receptor type 1 ) | 0.67452 | 0 | 0 | 0 | 0 |
7 | hsa64805 ( purinergic receptor P2Y12 ) | 0.647987 | 0 | 0 | 0 | 0 |
8 | hsa1813 ( dopamine receptor D2 ) | 0.623315 | 0 | 0 | 0 | 0 |
9 | hsa1131 ( cholinergic receptor muscarinic 3 ) | 0.616858 | 0 | 0 | 0 | 0 |
10 | hsa5724 ( platelet activating factor receptor ) | 0.611332 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.842998 | 0 | 0 | 0 | 0 |
2 | hsa4988 ( opioid receptor mu 1 ) | 0.807235 | 0 | 0 | 0 | 0 |
3 | hsa1234 ( C-C motif chemokine receptor 5 (gene/pseudogene) ) | 0.695339 | 0 | 0 | 0 | 0 |
4 | hsa8843 ( hydroxycarboxylic acid receptor 3 ) | 0.643097 | 0 | 0 | 0 | 0 |
5 | hsa4986 ( opioid receptor kappa 1 ) | 0.638405 | 0 | 0 | 0 | 0 |
6 | hsa148 ( adrenoceptor alpha 1A ) | 0.626098 | 0 | 0 | 0 | 0 |
7 | hsa64805 ( purinergic receptor P2Y12 ) | 0.604627 | 0 | 0 | 0 | 0 |
8 | hsa136 ( adenosine A2b receptor ) | 0.598858 | 0 | 0 | 0 | 0 |
9 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.585387 | 0 | 0 | 0 | 0 |
10 | hsa10800 ( cysteinyl leukotriene receptor 1 ) | 0.581703 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa185 ( angiotensin II receptor type 1 ) | 0.824409 | 0 | 0 | 0 | 0 |
2 | hsa1812 ( dopamine receptor D1 ) | 0.807243 | 0 | 0 | 0 | 0 |
3 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.804918 | 0 | 0 | 0 | 0 |
4 | hsa1814 ( dopamine receptor D3 ) | 0.766542 | 0 | 0 | 0 | 0 |
5 | hsa1813 ( dopamine receptor D2 ) | 0.745837 | 0 | 0 | 0 | 0 |
6 | hsa6752 ( somatostatin receptor 2 ) | 0.725042 | 0 | 0 | 0 | 0 |
7 | hsa6755 ( somatostatin receptor 5 ) | 0.720721 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.68895 | 0 | 0 | 0 | 0 |
9 | hsa6753 ( somatostatin receptor 3 ) | 0.675446 | 0 | 0 | 0 | 0 |
10 | hsa4543 ( melatonin receptor 1A ) | 0.653687 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa5731 ( prostaglandin E receptor 1 ) | 0.782229 | 0 | 0 | 0 | 0 |
2 | hsa5739 ( prostaglandin I2 (prostacyclin) receptor (IP) ) | 0.761265 | 0 | 0 | 0 | 0 |
3 | hsa5732 ( prostaglandin E receptor 2 ) | 0.736276 | 0 | 0 | 0 | 0 |
4 | hsa4988 ( opioid receptor mu 1 ) | 0.734574 | 0 | 0 | 0 | 0 |
5 | hsa5733 ( prostaglandin E receptor 3 ) | 0.705143 | 0 | 0 | 0 | 0 |
6 | hsa154 ( adrenoceptor beta 2 ) | 0.702351 | 0 | 0 | 0 | 0 |
7 | hsa5737 ( prostaglandin F receptor ) | 0.695542 | 0 | 0 | 0 | 0 |
8 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.693113 | 0 | 0 | 0 | 0 |
9 | hsa153 ( adrenoceptor beta 1 ) | 0.692357 | 0 | 0 | 0 | 0 |
10 | hsa64805 ( purinergic receptor P2Y12 ) | 0.674123 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.95499 | 1 | 0 | 1 | 0 |
2 | hsa3350 ( 5-hydroxytryptamine receptor 1A ) | 0.882607 | 0 | 0 | 0 | 0 |
3 | hsa3354 ( 5-hydroxytryptamine receptor 1E ) | 0.851109 | 0 | 0 | 0 | 0 |
4 | hsa3361 ( 5-hydroxytryptamine receptor 5A ) | 0.824944 | 0 | 0 | 0 | 0 |
5 | hsa148 ( adrenoceptor alpha 1A ) | 0.821523 | 0 | 0 | 0 | 0 |
6 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.798519 | 0 | 0 | 0 | 0 |
7 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.795745 | 0 | 0 | 0 | 0 |
8 | hsa3357 ( 5-hydroxytryptamine receptor 2B ) | 0.794006 | 0 | 0 | 0 | 0 |
9 | hsa150 ( adrenoceptor alpha 2A ) | 0.78352 | 0 | 0 | 0 | 0 |
10 | hsa1814 ( dopamine receptor D3 ) | 0.757598 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa153 ( adrenoceptor beta 1 ) | 0.970721 | 0 | 0 | 0 | 0 |
2 | hsa155 ( adrenoceptor beta 3 ) | 0.921864 | 0 | 0 | 0 | 0 |
3 | hsa148 ( adrenoceptor alpha 1A ) | 0.715337 | 0 | 0 | 0 | 0 |
4 | hsa3274 ( histamine receptor H2 ) | 0.665332 | 0 | 0 | 0 | 0 |
5 | hsa3360 ( 5-hydroxytryptamine receptor 4 ) | 0.649515 | 0 | 0 | 0 | 0 |
6 | hsa150 ( adrenoceptor alpha 2A ) | 0.628491 | 0 | 0 | 0 | 0 |
7 | hsa1812 ( dopamine receptor D1 ) | 0.607727 | 0 | 0 | 0 | 0 |
8 | hsa146 ( adrenoceptor alpha 1D ) | 0.600438 | 0 | 0 | 0 | 0 |
9 | hsa151 ( adrenoceptor alpha 2B ) | 0.596143 | 0 | 0 | 0 | 0 |
10 | hsa147 ( adrenoceptor alpha 1B ) | 0.566724 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa4986 ( opioid receptor kappa 1 ) | 0.916645 | 1 | 0 | 1 | 0 |
2 | hsa4985 ( opioid receptor delta 1 ) | 0.834146 | 1 | 0 | 1 | 0 |
3 | hsa185 ( angiotensin II receptor type 1 ) | 0.770519 | 0 | 0 | 0 | 0 |
4 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.738489 | 0 | 0 | 0 | 0 |
5 | hsa3269 ( histamine receptor H1 ) | 0.698397 | 0 | 0 | 0 | 0 |
6 | hsa1129 ( cholinergic receptor muscarinic 2 ) | 0.684327 | 0 | 0 | 0 | 0 |
7 | hsa6752 ( somatostatin receptor 2 ) | 0.676517 | 0 | 0 | 0 | 0 |
8 | hsa7201 ( thyrotropin releasing hormone receptor ) | 0.655866 | 0 | 0 | 0 | 0 |
9 | hsa1813 ( dopamine receptor D2 ) | 0.648657 | 0 | 0 | 0 | 0 |
10 | hsa3577 ( C-X-C motif chemokine receptor 1 ) | 0.642935 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.85986 | 0 | 0 | 0 | 0 |
2 | hsa153 ( adrenoceptor beta 1 ) | 0.767239 | 0 | 0 | 0 | 0 |
3 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.740125 | 0 | 0 | 0 | 0 |
4 | hsa1812 ( dopamine receptor D1 ) | 0.731822 | 0 | 0 | 0 | 0 |
5 | hsa3352 ( 5-hydroxytryptamine receptor 1D ) | 0.731021 | 0 | 0 | 0 | 0 |
6 | hsa3351 ( 5-hydroxytryptamine receptor 1B ) | 0.727055 | 0 | 0 | 0 | 0 |
7 | hsa3362 ( 5-hydroxytryptamine receptor 6 ) | 0.726007 | 0 | 0 | 0 | 0 |
8 | hsa3269 ( histamine receptor H1 ) | 0.725621 | 0 | 0 | 0 | 0 |
9 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.716038 | 0 | 0 | 0 | 0 |
10 | hsa3358 ( 5-hydroxytryptamine receptor 2C ) | 0.708145 | 0 | 0 | 0 | 0 |
Rank | Target | Score | Validated | KEGG | DrugBank | Matador |
---|---|---|---|---|---|---|
1 | hsa154 ( adrenoceptor beta 2 ) | 0.797695 | 0 | 0 | 0 | 0 |
2 | hsa3269 ( histamine receptor H1 ) | 0.744703 | 0 | 0 | 0 | 0 |
3 | hsa1128 ( cholinergic receptor muscarinic 1 ) | 0.718604 | 0 | 0 | 0 | 0 |
4 | hsa1812 ( dopamine receptor D1 ) | 0.705934 | 0 | 0 | 0 | 0 |
5 | hsa3274 ( histamine receptor H2 ) | 0.698499 | 0 | 0 | 0 | 0 |
6 | hsa148 ( adrenoceptor alpha 1A ) | 0.696978 | 0 | 0 | 0 | 0 |
7 | hsa3356 ( 5-hydroxytryptamine receptor 2A ) | 0.695641 | 0 | 0 | 0 | 0 |
8 | hsa153 ( adrenoceptor beta 1 ) | 0.683959 | 0 | 0 | 0 | 0 |
9 | hsa3352 ( 5-hydroxytryptamine receptor 1D ) | 0.680044 | 0 | 0 | 0 | 0 |
10 | hsa3355 ( 5-hydroxytryptamine receptor 1F ) | 0.67705 | 0 | 0 | 0 | 0 |